Search type: go_term
Results for query: apoptotic process
| Gene Symbol | Gene Name | Links to Senescence |
|---|---|---|
| AATF | apoptosis antagonizing transcription factor |
U: 1
D: 1
|
| ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase |
U: 1
|
| ABR | ABR activator of RhoGEF and GTPase |
U: 2
|
| ACER2 | alkaline ceramidase 2 |
U: 3
|
| ACTC1 | actin, alpha, cardiac muscle 1 |
U: 2
|
| ACTN1 | actinin alpha 1 |
U: 3
D: 1
|
| ACTN4 | actinin alpha 4 |
U: 3
D: 1
|
| ACVR1C | activin A receptor, type IC |
U: 1
|
| ADA | adenosine deaminase |
D: 1
|
| ADAM10 | a disintegrin and metallopeptidase domain 10 |
U: 3
D: 2
|
| ADAM15 | ADAM metallopeptidase domain 15 |
U: 1
|
| ADAM17 | a disintegrin and metallopeptidase domain 17 |
U: 3
D: 2
|
| ADAM8 | a disintegrin and metallopeptidase domain 8 |
D: 1
|
| ADAMTSL4 | ADAMTS-like 4 |
U: 3
|
| ADAR | adenosine deaminase, RNA-specific |
U: 1
|
| ADCY10 | adenylate cyclase 10 |
U: 1
|
| ADIPOQ | adiponectin, C1Q and collagen domain containing |
U: 2
D: 4
|
| ADM | adrenomedullin |
U: 2
D: 2
|
| ADNP | activity-dependent neuroprotective protein |
D: 1
|
| ADORA1 | adenosine A1 receptor |
D: 1
|
| AGO4 | argonaute RISC catalytic subunit 4 |
D: 1
|
| AGT | angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
U: 4
D: 1
|
| AHI1 | Abelson helper integration site 1 |
U: 1
D: 1
|
| AHR | aryl hydrocarbon receptor |
U: 3
D: 2
|
| AIFM2 | apoptosis-inducing factor, mitochondrion-associated 2 |
D: 1
|
| AIM2 | absent in melanoma 2 |
U: 1
|
| AIMP1 | aminoacyl tRNA synthetase complex-interacting multifunctional protein 1 |
D: 1
|
| AIMP2 | aminoacyl tRNA synthetase complex-interacting multifunctional protein 2 |
D: 1
|
| AKAP12 | A kinase (PRKA) anchor protein (gravin) 12 |
U: 2
D: 2
|
| AKAP13 | A-kinase anchoring protein 13 |
U: 1
|
| AKR1B1 | aldo-keto reductase family 1 member B |
U: 4
D: 2
|
| AKR1C3 | aldo-keto reductase family 1 member C3 |
U: 2
D: 3
|
| AKT1 | thymoma viral proto-oncogene 1 |
U: 21
D: 24
|
| AKT1S1 | AKT1 substrate 1 (proline-rich) |
U: 2
|
| AKT2 | thymoma viral proto-oncogene 2 |
U: 1
|
| AKTIP | thymoma viral proto-oncogene 1 interacting protein |
U: 1
D: 2
|
| ALDH1A2 | aldehyde dehydrogenase family 1, subfamily A2 |
D: 1
|
| ALDH1A3 | aldehyde dehydrogenase family 1, subfamily A3 |
U: 6
|
| ALK | ALK receptor tyrosine kinase |
U: 1
D: 1
|
| ALKBH1 | alkB homolog 1, histone H2A dioxygenase |
D: 2
|
| ALOX12 | arachidonate 12-lipoxygenase |
U: 1
|
| ALOX15B | arachidonate 15-lipoxygenase type B |
U: 6
|
| ALPK2 | alpha-kinase 2 |
U: 1
D: 1
|
| AMBRA1 | autophagy/beclin 1 regulator 1 |
D: 2
|
| AMIGO2 | adhesion molecule with Ig like domain 2 |
U: 1
D: 2
|
| ANGPT1 | angiopoietin 1 |
U: 3
D: 3
|
| ANGPT4 | angiopoietin 4 |
U: 1
|
| ANGPTL4 | angiopoietin-like 4 |
U: 7
D: 1
|
| ANKRD1 | ankyrin repeat domain 1 (cardiac muscle) |
U: 3
|
| ANO6 | anoctamin 6 |
U: 1
|
| ANP32A | acidic (leucine-rich) nuclear phosphoprotein 32 family, member A |
U: 1
D: 1
|
| ANP32B | acidic (leucine-rich) nuclear phosphoprotein 32 family, member B |
U: 1
D: 3
|
| ANP32E | acidic (leucine-rich) nuclear phosphoprotein 32 family, member E |
D: 1
|
| ANXA1 | annexin A1 |
U: 2
|
| ANXA4 | annexin A4 |
U: 1
|
| ANXA5 | annexin A5 |
U: 1
D: 1
|
| APAF1 | apoptotic peptidase activating factor 1 |
U: 1
D: 1
|
| APBB1 | amyloid beta (A4) precursor protein-binding, family B, member 1 |
U: 1
|
| APBB2 | amyloid beta (A4) precursor protein-binding, family B, member 2 |
U: 1
D: 1
|
| APC | APC, WNT signaling pathway regulator |
D: 2
|
| APEX1 | apurinic/apyrimidinic endonuclease 1 |
U: 1
D: 2
|
| APH1A | aph-1 homolog A, gamma-secretase subunit |
D: 1
|
| API5 | apoptosis inhibitor 5 |
D: 1
|
| APIP | APAF1 interacting protein |
U: 1
D: 1
|
| APLP1 | amyloid beta (A4) precursor-like protein 1 |
U: 6
|
| APOE | apolipoprotein E |
U: 4
D: 1
|
| APP | amyloid beta (A4) precursor protein |
U: 6
D: 1
|
| AQP1 | aquaporin 1 |
U: 1
D: 1
|
| ARF4 | ADP-ribosylation factor 4 |
U: 1
|
| ARF6 | ADP-ribosylation factor 6 |
D: 1
|
| ARG2 | arginase type II |
U: 5
D: 2
|
| ARHGAP10 | Rho GTPase activating protein 10 |
U: 1
D: 1
|
| ARHGDIA | Rho GDP dissociation inhibitor alpha |
U: 2
|
| ARHGEF12 | Rho guanine nucleotide exchange factor 12 |
U: 1
|
| ARHGEF16 | Rho guanine nucleotide exchange factor 16 |
U: 3
|
| ARHGEF17 | Rho guanine nucleotide exchange factor 17 |
D: 1
|
| ARHGEF19 | Rho guanine nucleotide exchange factor 19 |
U: 2
|
| ARHGEF2 | Rho/Rac guanine nucleotide exchange factor 2 |
D: 2
|
| ARHGEF26 | Rho guanine nucleotide exchange factor 26 |
U: 1
D: 2
|
| ARHGEF3 | Rho guanine nucleotide exchange factor 3 |
U: 1
|
| ARHGEF4 | Rho guanine nucleotide exchange factor 4 |
U: 2
|
| ARHGEF6 | Rac/Cdc42 guanine nucleotide exchange factor 6 |
D: 1
|
| ARL6IP1 | ADP-ribosylation factor-like 6 interacting protein 1 |
D: 2
|
| ARL6IP5 | ADP-ribosylation factor-like 6 interacting protein 5 |
U: 2
|
| ARNT2 | aryl hydrocarbon receptor nuclear translocator 2 |
U: 1
D: 2
|
| ARRB1 | arrestin, beta 1 |
U: 2
D: 1
|
| ARRB2 | arrestin, beta 2 |
D: 1
|
| ASCL1 | achaete-scute family bHLH transcription factor 1 |
D: 1
|
| ASIC2 | acid-sensing (proton-gated) ion channel 2 |
U: 1
|
| ASNS | asparagine synthetase |
U: 1
D: 2
|
| ATAD3A | ATPase family, AAA domain containing 3A |
D: 1
|
| ATCAY | ataxia, cerebellar, Cayman type |
D: 1
|
| ATF2 | activating transcription factor 2 |
D: 1
|
| ATF4 | activating transcription factor 4 |
U: 2
D: 1
|
| ATF5 | activating transcription factor 5 |
U: 3
|
| ATF6 | activating transcription factor 6 |
U: 4
|
| ATG3 | autophagy related 3 |
D: 2
|
| ATG4D | autophagy related 4D, cysteine peptidase |
U: 2
|
| ATG5 | autophagy related 5 |
U: 3
D: 3
|
| ATG7 | autophagy related 7 |
U: 3
D: 3
|
| ATM | ataxia telangiectasia mutated |
U: 28
D: 1
|
| ATN1 | atrophin 1 |
D: 2
|
| ATOX1 | antioxidant 1 copper chaperone |
U: 2
|
| ATP2A3 | ATPase, Ca++ transporting, ubiquitous |
U: 3
|
| AURKA | aurora kinase A |
D: 18
|
| AURKB | aurora kinase B |
D: 13
|
| AVEN | apoptosis, caspase activation inhibitor |
U: 1
D: 2
|
| AXIN1 | axin 1 |
U: 1
D: 1
|
| AXL | AXL receptor tyrosine kinase |
U: 1
D: 4
|
| AAMDC | adipogenesis associated Mth938 domain containing |
U: 1
D: 2
|
| AARS | alanyl-tRNA synthetase |
U: 1
D: 1
|
| AATK | apoptosis-associated tyrosine kinase |
U: 1
|
| ABL2 | v-abl Abelson murine leukemia viral oncogene 2 (arg, Abelson-related gene) |
U: 2
|
| ACE | angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
U: 3
|
| ACIN1 | apoptotic chromatin condensation inducer 1 |
D: 2
|
| ACOT1 | acyl-CoA thioesterase 1 |
U: 1
|
| ADRB2 | adrenergic receptor, beta 2 |
U: 1
|
| AEN | apoptosis enhancing nuclease |
U: 1
|
| AGER | advanced glycosylation end product-specific receptor |
U: 2
D: 1
|
| AGRN | agrin |
U: 4
|
| AGTR2 | angiotensin II receptor, type 2 |
D: 1
|
| ALDH1A1 | aldehyde dehydrogenase family 1, subfamily A1 |
U: 2
D: 1
|
| ALDH2 | aldehyde dehydrogenase 2, mitochondrial |
U: 2
D: 1
|
| ALDOC | aldolase C, fructose-bisphosphate |
U: 2
D: 1
|
| ALMS1 | ALMS1, centrosome and basal body associated |
D: 2
|
| ANK2 | ankyrin 2, brain |
U: 2
D: 2
|
| APBB3 | amyloid beta (A4) precursor protein-binding, family B, member 3 |
U: 1
|
| ARMC10 | armadillo repeat containing 10 |
U: 1
D: 1
|
| ATP7A | ATPase, Cu++ transporting, alpha polypeptide |
U: 2
|
| B4GALT1 | UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 |
U: 2
|
| BABAM2 | BRISC and BRCA1 A complex member 2 |
U: 1
D: 1
|
| BACE1 | beta-site APP cleaving enzyme 1 |
U: 3
D: 1
|
| BAG1 | BCL2-associated athanogene 1 |
U: 2
D: 1
|
| BAG3 | BCL2-associated athanogene 3 |
U: 2
D: 1
|
| BAK1 | BCL2-antagonist/killer 1 |
U: 4
D: 1
|
| BARD1 | BRCA1 associated RING domain 1 |
U: 1
D: 4
|
| BAX | BCL2-associated X protein |
U: 7
|
| BBC3 | BCL2 binding component 3 |
U: 4
D: 1
|
| BCAP29 | B cell receptor associated protein 29 |
U: 2
D: 1
|
| BCAP31 | B cell receptor associated protein 31 |
U: 2
|
| BCL10 | B cell leukemia/lymphoma 10 |
U: 1
D: 1
|
| BCL11B | B cell leukemia/lymphoma 11B |
U: 1
|
| BCL2 | B cell leukemia/lymphoma 2 |
U: 11
D: 5
|
| BCL2A1 | BCL2 related protein A1 |
U: 4
|
| BCL2L1 | BCL2-like 1 |
U: 11
D: 6
|
| BCL2L10 | Bcl2-like 10 |
U: 1
|
| BCL2L11 | BCL2-like 11 (apoptosis facilitator) |
U: 1
|
| BCL2L12 | BCL2-like 12 (proline rich) |
D: 1
|
| BCL2L13 | BCL2-like 13 (apoptosis facilitator) |
U: 1
|
| BCL2L2 | BCL2-like 2 |
U: 2
|
| BCL3 | B cell leukemia/lymphoma 3 |
U: 1
D: 2
|
| BCL6 | B cell leukemia/lymphoma 6 |
U: 3
D: 1
|
| BCL7B | B cell CLL/lymphoma 7B |
U: 1
|
| BCL7C | B cell CLL/lymphoma 7C |
D: 1
|
| BCLAF1 | BCL2-associated transcription factor 1 |
D: 1
|
| BDNF | brain derived neurotrophic factor |
U: 1
|
| BECN1 | beclin 1, autophagy related |
U: 6
D: 8
|
| BEX2 | brain expressed X-linked 2 |
U: 1
|
| BEX3 | brain expressed X-linked 3 |
U: 2
|
| BID | BH3 interacting domain death agonist |
U: 5
|
| BIK | BCL2-interacting killer |
U: 2
|
| BIN1 | bridging integrator 1 |
U: 1
|
| BIRC2 | baculoviral IAP repeat-containing 2 |
U: 1
D: 1
|
| BIRC3 | baculoviral IAP repeat-containing 3 |
U: 3
D: 1
|
| BIRC5 | baculoviral IAP repeat-containing 5 |
U: 3
D: 14
|
| BIRC6 | baculoviral IAP repeat-containing 6 |
U: 1
|
| BLK | B lymphoid kinase |
U: 1
|
| BMF | BCL2 modifying factor |
U: 4
D: 2
|
| BMP2 | bone morphogenetic protein 2 |
U: 6
D: 1
|
| BMP4 | bone morphogenetic protein 4 |
U: 4
D: 1
|
| BMP7 | bone morphogenetic protein 7 |
U: 5
D: 3
|
| BMPR1A | bone morphogenetic protein receptor, type 1A |
D: 1
|
| BMPR2 | bone morphogenetic protein receptor, type II (serine/threonine kinase) |
U: 1
|
| BNIP1 | BCL2/adenovirus E1B interacting protein 1 |
D: 1
|
| BNIP2 | BCL2/adenovirus E1B interacting protein 2 |
U: 1
|
| BNIP3L | BCL2/adenovirus E1B interacting protein 3-like |
U: 2
|
| BOK | BCL2-related ovarian killer |
U: 3
|
| BRAF | Braf transforming gene |
U: 24
D: 4
|
| BRAT1 | BRCA1-associated ATM activator 1 |
U: 2
|
| BRCA1 | BRCA1 DNA repair associated |
U: 2
D: 10
|
| BRMS1 | breast cancer metastasis-suppressor 1 |
U: 1
D: 1
|
| BTC | betacellulin, epidermal growth factor family member |
U: 2
|
| BTG2 | BTG anti-proliferation factor 2 |
U: 8
D: 2
|
| BTK | Bruton agammaglobulinemia tyrosine kinase |
U: 4
D: 1
|
| BUB1 | BUB1, mitotic checkpoint serine/threonine kinase |
D: 9
|
| BUB1B | BUB1B, mitotic checkpoint serine/threonine kinase |
D: 9
|
| BLCAP | bladder cancer associated protein |
U: 2
|
| BLM | Bloom syndrome, RecQ like helicase |
D: 6
|
| BNC2 | basonuclin 2 |
D: 1
|
| C19ORF12 | chromosome 19 open reading frame 12 |
U: 1
|
| C1QBP | complement component 1, q subcomponent binding protein |
U: 1
D: 3
|
| C5AR1 | complement component 5a receptor 1 |
U: 2
|
| CADM1 | cell adhesion molecule 1 |
U: 2
|
| CALR | calreticulin |
D: 3
|
| CAMK2A | calcium/calmodulin-dependent protein kinase II alpha |
U: 1
D: 3
|
| CAMK2D | calcium/calmodulin-dependent protein kinase II, delta |
D: 1
|
| CAPN2 | calpain 2 |
U: 2
D: 1
|
| CAPN3 | calpain 3 |
U: 1
|
| CARD10 | caspase recruitment domain family, member 10 |
U: 1
D: 1
|
| CARD11 | caspase recruitment domain family, member 11 |
D: 2
|
| CARD14 | caspase recruitment domain family, member 14 |
U: 1
|
| CARD16 | caspase recruitment domain family member 16 |
D: 1
|
| CARD8 | caspase recruitment domain family member 8 |
D: 1
|
| CARD9 | caspase recruitment domain family, member 9 |
U: 1
|
| CASC2 | cancer susceptibility 2 |
D: 1
|
| CASP1 | caspase 1 |
U: 2
D: 3
|
| CASP10 | caspase 10 |
U: 3
|
| CASP2 | caspase 2 |
U: 2
D: 1
|
| CASP3 | caspase 3 |
U: 3
D: 5
|
| CASP4 | caspase 4, apoptosis-related cysteine peptidase |
U: 2
D: 2
|
| CASP5 | caspase 5 |
U: 1
|
| CASP7 | caspase 7 |
U: 2
D: 1
|
| CASP8 | caspase 8 |
U: 1
D: 1
|
| CASP8AP2 | caspase 8 associated protein 2 |
D: 3
|
| CASP9 | caspase 9 |
U: 1
|
| CASR | calcium sensing receptor |
D: 1
|
| CAST | calpastatin |
U: 2
D: 1
|
| CAT | catalase |
U: 2
D: 1
|
| CBL | Casitas B-lineage lymphoma |
U: 1
D: 1
|
| CBX4 | chromobox 4 |
D: 2
|
| CCAR1 | cell division cycle and apoptosis regulator 1 |
D: 1
|
| CCAR2 | cell cycle activator and apoptosis regulator 2 |
U: 1
D: 1
|
| CCL2 | C-C motif chemokine ligand 2 |
U: 39
D: 4
|
| CCL3 | chemokine (C-C motif) ligand 3 |
U: 11
|
| CCL5 | chemokine (C-C motif) ligand 5 |
U: 13
D: 1
|
| CCN1 | cellular communication network factor 1 |
U: 4
D: 2
|
| CCN2 | cellular communication network factor 2 |
U: 2
D: 3
|
| CCND2 | cyclin D2 |
U: 5
D: 2
|
| CCR7 | chemokine (C-C motif) receptor 7 |
U: 2
|
| CD14 | CD14 molecule |
U: 2
|
| CD248 | CD248 antigen, endosialin |
U: 1
|
| CD27 | CD27 antigen |
D: 1
|
| CD274 | CD274 antigen |
U: 2
D: 1
|
| CD28 | CD28 molecule |
U: 1
D: 1
|
| CD38 | CD38 antigen |
U: 2
D: 1
|
| CD40 | CD40 antigen |
U: 1
|
| CD40LG | CD40 ligand |
U: 1
|
| CD44 | CD44 antigen |
U: 6
D: 2
|
| CD74 | CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated) |
D: 1
|
| CDC34 | cell division cycle 34 |
U: 2
D: 1
|
| CDC42 | cell division cycle 42 |
U: 3
|
| CDC73 | cell division cycle 73, Paf1/RNA polymerase II complex component |
U: 1
D: 1
|
| CDCA7 | cell division cycle associated 7 |
D: 3
|
| CDH5 | cadherin 5 |
D: 1
|
| CDIP1 | cell death inducing Trp53 target 1 |
U: 3
|
| CDK1 | cyclin-dependent kinase 1 |
U: 1
D: 11
|
| CDK11A | cyclin dependent kinase 11A |
U: 1
|
| CDK4 | cyclin-dependent kinase 4 |
U: 1
D: 17
|
| CDK5 | cyclin-dependent kinase 5 |
U: 3
|
| CDK5R1 | cyclin-dependent kinase 5, regulatory subunit 1 (p35) |
U: 2
D: 2
|
| CDKN1A | cyclin-dependent kinase inhibitor 1A (P21) |
U: 208
D: 24
|
| CDKN1B | cyclin-dependent kinase inhibitor 1B |
U: 22
D: 4
|
| CDKN2A | cyclin dependent kinase inhibitor 2A |
U: 238
D: 5
|
| CDKN2D | cyclin dependent kinase inhibitor 2D |
U: 5
D: 1
|
| CEACAM6 | CEA cell adhesion molecule 6 |
U: 1
|
| CEBPB | CCAAT/enhancer binding protein (C/EBP), beta |
U: 9
D: 1
|
| CFDP1 | craniofacial development protein 1 |
D: 3
|
| CFL1 | cofilin 1 |
D: 2
|
| CFLAR | CASP8 and FADD-like apoptosis regulator |
U: 1
|
| CGB3 | chorionic gonadotropin subunit beta 3 |
U: 1
|
| CGB7 | chorionic gonadotropin subunit beta 7 |
U: 1
|
| CHD8 | chromodomain helicase DNA binding protein 8 |
U: 1
|
| CHEK1 | checkpoint kinase 1 |
U: 3
D: 9
|
| CHI3L1 | chitinase 3 like 1 |
U: 4
|
| CHL1 | cell adhesion molecule L1-like |
D: 1
|
| CHM | CHM Rab escort protein |
U: 1
|
| CHMP3 | charged multivesicular body protein 3 |
U: 1
D: 1
|
| CHST11 | carbohydrate sulfotransferase 11 |
U: 1
D: 1
|
| CIAPIN1 | cytokine induced apoptosis inhibitor 1 |
U: 1
|
| CIB1 | calcium and integrin binding 1 (calmyrin) |
D: 1
|
| CIT | citron |
D: 5
|
| CITED1 | Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 1 |
D: 1
|
| CITED2 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
U: 1
D: 3
|
| CKAP2 | cytoskeleton associated protein 2 |
D: 3
|
| CLCF1 | cardiotrophin-like cytokine factor 1 |
U: 1
|
| CLDN7 | claudin 7 |
D: 1
|
| CLIP3 | CAP-GLY domain containing linker protein 3 |
U: 4
|
| CLN3 | ceroid lipofuscinosis, neuronal 3, juvenile (Batten, Spielmeyer-Vogt disease) |
U: 1
|
| CLPTM1L | CLPTM1-like |
U: 1
|
| CLU | clusterin |
U: 3
D: 4
|
| CNR1 | cannabinoid receptor 1 (brain) |
D: 1
|
| CNTFR | ciliary neurotrophic factor receptor |
U: 1
D: 1
|
| COL18A1 | collagen, type XVIII, alpha 1 |
U: 2
D: 1
|
| COMP | cartilage oligomeric matrix protein |
U: 2
D: 1
|
| COPS5 | COP9 signalosome subunit 5 |
U: 1
D: 3
|
| CORO1A | coronin, actin binding protein 1A |
D: 2
|
| CPEB4 | cytoplasmic polyadenylation element binding protein 4 |
U: 1
|
| CRADD | CASP2 and RIPK1 domain containing adaptor with death domain |
U: 1
D: 1
|
| CREB1 | cAMP responsive element binding protein 1 |
D: 2
|
| CREBBP | CREB binding protein |
U: 1
D: 2
|
| CRKL | v-crk avian sarcoma virus CT10 oncogene homolog-like |
U: 1
D: 1
|
| CRLF1 | cytokine receptor-like factor 1 |
U: 3
D: 1
|
| CRYAB | crystallin, alpha B |
U: 4
|
| CSF1R | colony stimulating factor 1 receptor |
U: 1
D: 1
|
| CSNK2A1 | casein kinase 2, alpha 1 polypeptide |
U: 5
D: 5
|
| CSRNP1 | cysteine-serine-rich nuclear protein 1 |
U: 1
D: 1
|
| CSRNP2 | cysteine-serine-rich nuclear protein 2 |
U: 1
D: 1
|
| CSRNP3 | cysteine-serine-rich nuclear protein 3 |
U: 1
|
| CST3 | cystatin C |
U: 3
|
| CTLA4 | cytotoxic T-lymphocyte-associated protein 4 |
U: 1
|
| CTNNB1 | catenin (cadherin associated protein), beta 1 |
U: 7
D: 2
|
| CTSB | cathepsin B |
U: 5
D: 1
|
| CTSC | cathepsin C |
D: 1
|
| CTSD | cathepsin D |
U: 4
D: 1
|
| CTSH | cathepsin H |
U: 3
|
| CTSL | cathepsin L |
U: 2
|
| CTSZ | cathepsin Z |
U: 4
D: 1
|
| CX3CL1 | chemokine (C-X3-C motif) ligand 1 |
U: 4
|
| CXCL10 | chemokine (C-X-C motif) ligand 10 |
U: 11
|
| CXCL12 | chemokine (C-X-C motif) ligand 12 |
U: 4
D: 3
|
| CXCR2 | chemokine (C-X-C motif) receptor 2 |
U: 5
|
| CXCR3 | C-X-C motif chemokine receptor 3 |
U: 1
|
| CXCR4 | C-X-C motif chemokine receptor 4 |
U: 6
D: 1
|
| CYCS | cytochrome c, somatic |
U: 2
|
| CYFIP2 | cytoplasmic FMR1 interacting protein 2 |
U: 3
|
| CYP1B1 | cytochrome P450, family 1, subfamily b, polypeptide 1 |
U: 4
D: 1
|
| CACNA1A | calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
U: 2
|
| CAPN1 | calpain 1 |
U: 1
D: 1
|
| CAV1 | caveolin 1, caveolae protein |
U: 15
D: 5
|
| CBS | cystathionine beta-synthase |
U: 2
D: 4
|
| CCNG1 | cyclin G1 |
U: 3
|
| CDH1 | cadherin 1 |
U: 2
|
| CERKL | ceramide kinase-like |
U: 1
|
| CFTR | cystic fibrosis transmembrane conductance regulator |
D: 1
|
| CHAC1 | ChaC, cation transport regulator 1 |
U: 2
D: 1
|
| CHEK2 | checkpoint kinase 2 |
U: 9
D: 5
|
| COA8 | cytochrome c oxidase assembly factor 8 | |
| CREB3 | cAMP responsive element binding protein 3 |
U: 1
|
| CTH | cystathionase (cystathionine gamma-lyase) |
D: 2
|
| CTNNA1 | catenin (cadherin associated protein), alpha 1 |
U: 1
|
| CUL7 | cullin 7 |
D: 1
|
| DAB2 | disabled 2, mitogen-responsive phosphoprotein |
U: 2
D: 1
|
| DAB2IP | disabled 2 interacting protein |
U: 1
|
| DAD1 | defender against cell death 1 |
U: 1
D: 1
|
| DAP | death-associated protein |
U: 1
|
| DAPK1 | death associated protein kinase 1 |
U: 2
|
| DAPK2 | death-associated protein kinase 2 |
U: 3
|
| DAPK3 | death-associated protein kinase 3 |
U: 2
|
| DAXX | Fas death domain-associated protein |
D: 1
|
| DCC | deleted in colorectal carcinoma |
U: 2
|
| DCUN1D3 | DCN1, defective in cullin neddylation 1, domain containing 3 (S. cerevisiae) |
U: 2
|
| DDB1 | damage specific DNA binding protein 1 |
U: 2
D: 1
|
| DDIAS | DNA damage-induced apoptosis suppressor |
D: 5
|
| DDIT3 | DNA-damage inducible transcript 3 |
U: 6
D: 1
|
| DDIT4 | DNA-damage-inducible transcript 4 |
U: 5
D: 4
|
| DDRGK1 | DDRGK domain containing 1 |
U: 3
|
| DHCR24 | 24-dehydrocholesterol reductase |
U: 3
D: 1
|
| DHODH | dihydroorotate dehydrogenase |
D: 1
|
| DHRS2 | dehydrogenase/reductase 2 |
U: 2
D: 2
|
| DIABLO | diablo, IAP-binding mitochondrial protein |
U: 1
|
| DIO3 | deiodinase, iodothyronine type III |
D: 1
|
| DIP2A | disco interacting protein 2 homolog A |
U: 1
|
| DIPK2A | divergent protein kinase domain 2A | |
| DKK1 | dickkopf WNT signaling pathway inhibitor 1 |
U: 7
D: 2
|
| DLC1 | deleted in liver cancer 1 |
D: 1
|
| DLG5 | discs large MAGUK scaffold protein 5 |
U: 2
|
| DLL1 | delta like canonical Notch ligand 1 |
U: 1
D: 1
|
| DLX1 | distal-less homeobox 1 |
D: 1
|
| DMPK | dystrophia myotonica-protein kinase |
U: 2
|
| DNAJA1 | DnaJ heat shock protein family (Hsp40) member A1 |
U: 1
|
| DNAJB6 | DnaJ heat shock protein family (Hsp40) member B6 |
U: 2
D: 1
|
| DNAJC3 | DnaJ heat shock protein family (Hsp40) member C3 |
U: 1
D: 1
|
| DNAJC5 | DnaJ heat shock protein family (Hsp40) member C5 |
U: 2
|
| DNM1L | dynamin 1-like |
U: 1
D: 6
|
| DNM2 | dynamin 2 |
U: 1
|
| DNMT1 | DNA methyltransferase (cytosine-5) 1 |
U: 2
D: 7
|
| DNMT3A | DNA methyltransferase 3 alpha |
D: 3
|
| DOCK1 | dedicator of cytokinesis 1 |
U: 2
|
| DOCK8 | dedicator of cytokinesis 8 |
U: 3
|
| DPEP1 | dipeptidase 1 |
D: 2
|
| DPF1 | double PHD fingers 1 |
U: 2
D: 2
|
| DPP8 | dipeptidyl peptidase 8 |
U: 1
D: 1
|
| DRAM1 | DNA-damage regulated autophagy modulator 1 |
U: 2
D: 2
|
| DRAM2 | DNA-damage regulated autophagy modulator 2 |
D: 1
|
| DRAXIN | dorsal inhibitory axon guidance protein |
U: 3
|
| DUSP1 | dual specificity phosphatase 1 |
U: 3
D: 2
|
| DUSP6 | dual specificity phosphatase 6 |
D: 2
|
| DUSP9 | dual specificity phosphatase 9 |
U: 1
|
| DYNLL1 | dynein light chain LC8-type 1 |
D: 1
|
| DYRK3 | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 3 |
U: 1
|
| DAP3 | death associated protein 3 |
D: 1
|
| DDX47 | DEAD box helicase 47 |
U: 1
|
| DEDD2 | death effector domain-containing DNA binding protein 2 |
U: 1
|
| DEGS1 | delta(4)-desaturase, sphingolipid 1 |
U: 1
|
| DFFB | DNA fragmentation factor, beta subunit |
D: 1
|
| DICER1 | dicer 1, ribonuclease type III |
D: 6
|
| DIDO1 | death inducer-obliterator 1 |
U: 1
|
| E2F1 | E2F transcription factor 1 |
U: 6
D: 13
|
| E2F2 | E2F transcription factor 2 |
U: 3
D: 5
|
| E2F3 | E2F transcription factor 3 |
U: 1
D: 2
|
| ECSCR | endothelial cell surface expressed chemotaxis and apoptosis regulator |
D: 1
|
| ECT2 | ect2 oncogene |
D: 3
|
| EDN1 | endothelin 1 |
U: 5
D: 1
|
| EDNRB | endothelin receptor type B |
U: 1
D: 1
|
| EEF1A2 | eukaryotic translation elongation factor 1 alpha 2 |
U: 2
|
| EEF1E1 | eukaryotic translation elongation factor 1 epsilon 1 |
U: 2
D: 1
|
| EEF2K | eukaryotic elongation factor-2 kinase |
D: 1
|
| EFNA1 | ephrin A1 |
U: 2
|
| EFNA5 | ephrin A5 |
U: 2
D: 1
|
| EGFR | epidermal growth factor receptor |
U: 1
D: 11
|
| EGR1 | early growth response 1 |
U: 4
D: 4
|
| EGR3 | early growth response 3 |
U: 1
D: 1
|
| EIF2AK2 | eukaryotic translation initiation factor 2-alpha kinase 2 |
U: 2
|
| EIF2AK3 | eukaryotic translation initiation factor 2 alpha kinase 3 |
U: 2
D: 1
|
| EIF2B5 | eukaryotic translation initiation factor 2B, subunit 5 epsilon |
D: 1
|
| EIF2S1 | eukaryotic translation initiation factor 2, subunit 1 alpha |
U: 1
D: 2
|
| EIF5A | eukaryotic translation initiation factor 5A |
D: 1
|
| ELMO1 | engulfment and cell motility 1 |
U: 1
D: 1
|
| ELMO3 | engulfment and cell motility 3 |
D: 1
|
| EN1 | engrailed 1 |
U: 2
|
| ENG | endoglin |
U: 4
D: 3
|
| EP300 | E1A binding protein p300 |
U: 3
D: 6
|
| EPB41L3 | erythrocyte membrane protein band 4.1 like 3 |
U: 1
D: 1
|
| EPCAM | epithelial cell adhesion molecule |
D: 2
|
| EPHA7 | Eph receptor A7 |
D: 2
|
| ERBB3 | erb-b2 receptor tyrosine kinase 3 |
U: 1
D: 1
|
| ERBB4 | erb-b2 receptor tyrosine kinase 4 |
U: 2
D: 1
|
| ERCC3 | excision repair cross-complementing rodent repair deficiency, complementation group 3 |
U: 1
|
| ERCC5 | excision repair cross-complementing rodent repair deficiency, complementation group 5 |
U: 1
|
| ESPL1 | extra spindle pole bodies like 1, separase |
D: 6
|
| ESR1 | estrogen receptor 1 (alpha) |
U: 2
D: 4
|
| EVA1A | eva-1 homolog A (C. elegans) |
U: 1
|
| EVI2B | ecotropic viral integration site 2b |
D: 2
|
| ECE1 | endothelin converting enzyme 1 |
U: 2
D: 1
|
| EDNRA | endothelin receptor type A |
D: 5
|
| EFHC1 | EF-hand domain (C-terminal) containing 1 |
U: 1
D: 1
|
| EGLN1 | egl-9 family hypoxia-inducible factor 1 |
U: 1
|
| ENDOG | endonuclease G |
U: 1
D: 1
|
| EPHA2 | Eph receptor A2 |
U: 2
D: 2
|
| ERBB2 | erb-b2 receptor tyrosine kinase 2 |
U: 9
|
| ERN1 | endoplasmic reticulum (ER) to nucleus signalling 1 |
U: 3
D: 2
|
| ERO1A | endoplasmic reticulum oxidoreductase 1 alpha |
U: 1
|
| ESR2 | estrogen receptor 2 (beta) |
U: 2
D: 1
|
| ETS1 | E26 avian leukemia oncogene 1, 5' domain |
U: 2
|
| F2R | coagulation factor II (thrombin) receptor |
U: 2
D: 1
|
| F3 | coagulation factor III, tissue factor |
U: 2
D: 1
|
| FAF1 | Fas-associated factor 1 |
D: 1
|
| FAIM | Fas apoptotic inhibitory molecule |
U: 1
|
| FAIM2 | Fas apoptotic inhibitory molecule 2 |
U: 1
D: 1
|
| FAM162A | family with sequence similarity 162, member A |
U: 2
D: 1
|
| FANK1 | fibronectin type 3 and ankyrin repeat domains 1 |
U: 2
|
| FAP | fibroblast activation protein |
U: 2
|
| FAS | Fas (TNF receptor superfamily member 6) |
U: 4
D: 1
|
| FASLG | Fas ligand |
U: 3
|
| FBXO10 | F-box protein 10 |
U: 1
|
| FCER1G | Fc receptor, IgE, high affinity I, gamma polypeptide |
U: 1
|
| FCMR | Fc fragment of IgM receptor |
U: 1
D: 1
|
| FFAR4 | free fatty acid receptor 4 |
U: 1
|
| FGD3 | FYVE, RhoGEF and PH domain containing 3 |
U: 2
D: 1
|
| FGD4 | FYVE, RhoGEF and PH domain containing 4 |
U: 2
|
| FGF4 | fibroblast growth factor 4 | |
| FGFR2 | fibroblast growth factor receptor 2 |
U: 3
D: 1
|
| FHL2 | four and a half LIM domains 2 |
U: 2
|
| FIGNL1 | fidgetin-like 1 |
U: 1
D: 1
|
| FIS1 | fission, mitochondrial 1 |
D: 2
|
| FLCN | folliculin |
U: 1
|
| FLNA | filamin, alpha |
U: 1
D: 2
|
| FLT3LG | fms related receptor tyrosine kinase 3 ligand |
U: 2
|
| FLT4 | FMS-like tyrosine kinase 4 |
U: 1
|
| FNIP1 | folliculin interacting protein 1 |
U: 2
|
| FOSL1 | fos-like antigen 1 |
U: 1
D: 2
|
| FOXA1 | forkhead box A1 |
U: 3
|
| FOXC1 | forkhead box C1 |
U: 2
D: 1
|
| FOXL2 | forkhead box L2 |
U: 1
|
| FOXO1 | forkhead box O1 |
U: 10
D: 3
|
| FOXO3 | forkhead box O3 |
U: 6
D: 10
|
| FOXP1 | forkhead box P1 |
U: 2
D: 2
|
| FOXQ1 | forkhead box Q1 |
U: 2
D: 2
|
| FRZB | frizzled-related protein |
U: 1
D: 1
|
| FXN | frataxin |
D: 2
|
| FXR1 | FMR1 autosomal homolog 1 |
D: 2
|
| FYN | Fyn proto-oncogene |
D: 2
|
| FZD5 | frizzled class receptor 5 |
U: 2
D: 1
|
| FZD9 | frizzled class receptor 9 |
U: 1
|
| FAM72A | family with sequence similarity 72, member A |
D: 1
|
| FASTK | Fas-activated serine/threonine kinase |
U: 1
|
| FBXO32 | F-box protein 32 |
U: 5
|
| FGFR3 | fibroblast growth factor receptor 3 |
U: 3
D: 1
|
| FHIT | fragile histidine triad gene |
U: 1
|
| FMR1 | FMRP translational regulator 1 |
D: 1
|
| FN1 | fibronectin 1 |
U: 7
D: 3
|
| FNDC1 | fibronectin type III domain containing 1 |
U: 3
|
| FNTA | farnesyltransferase, CAAX box, alpha |
U: 1
D: 1
|
| FOLH1 | folate hydrolase 1 |
U: 1
|
| G0S2 | G0/G1 switch gene 2 |
U: 2
D: 1
|
| G2E3 | G2/M-phase specific E3 ubiquitin ligase |
D: 4
|
| G6PD | glucose-6-phosphate dehydrogenase |
D: 3
|
| GABRA5 | gamma-aminobutyric acid (GABA) A receptor, subunit alpha 5 |
U: 1
D: 1
|
| GABRB3 | gamma-aminobutyric acid (GABA) A receptor, subunit beta 3 |
U: 1
|
| GADD45A | growth arrest and DNA-damage-inducible 45 alpha |
U: 7
D: 1
|
| GADD45B | growth arrest and DNA-damage-inducible 45 beta |
U: 5
D: 1
|
| GADD45G | growth arrest and DNA-damage-inducible 45 gamma |
U: 4
D: 1
|
| GAL | galanin and GMAP prepropeptide |
U: 2
|
| GAPDH | glyceraldehyde-3-phosphate dehydrogenase |
U: 2
D: 4
|
| GAS1 | growth arrest specific 1 |
U: 1
D: 3
|
| GAS6 | growth arrest specific 6 |
U: 3
D: 2
|
| GATA1 | GATA binding protein 1 |
U: 1
|
| GATA3 | GATA binding protein 3 |
U: 1
|
| GATA4 | GATA binding protein 4 |
U: 5
|
| GATA6 | GATA binding protein 6 |
U: 4
|
| GCG | glucagon |
D: 1
|
| GCLC | glutamate-cysteine ligase, catalytic subunit |
U: 2
D: 1
|
| GCLM | glutamate-cysteine ligase, modifier subunit |
U: 1
D: 4
|
| GDF5 | growth differentiation factor 5 |
U: 1
D: 1
|
| GDF6 | growth differentiation factor 6 |
U: 2
|
| GDNF | glial cell line derived neurotrophic factor |
U: 5
|
| GJA1 | gap junction protein, alpha 1 |
U: 2
D: 2
|
| GLI2 | GLI-Kruppel family member GLI2 |
D: 1
|
| GLI3 | GLI-Kruppel family member GLI3 |
D: 2
|
| GLO1 | glyoxalase 1 |
U: 1
D: 2
|
| GLRX2 | glutaredoxin 2 |
D: 1
|
| GLS2 | glutaminase 2 (liver, mitochondrial) |
U: 1
|
| GNA13 | G protein subunit alpha 13 |
U: 2
|
| GNB1 | guanine nucleotide binding protein (G protein), beta 1 |
U: 1
D: 1
|
| GNRH1 | gonadotropin releasing hormone 1 |
D: 1
|
| GOLPH3 | golgi phosphoprotein 3 |
D: 1
|
| GPER1 | G protein-coupled estrogen receptor 1 |
U: 1
D: 1
|
| GPLD1 | glycosylphosphatidylinositol specific phospholipase D1 |
U: 2
|
| GPX1 | glutathione peroxidase 1 |
U: 4
D: 6
|
| GRAMD4 | GRAM domain containing 4 |
U: 2
D: 1
|
| GRID2 | glutamate receptor, ionotropic, delta 2 |
D: 1
|
| GRIK5 | glutamate receptor, ionotropic, kainate 5 (gamma 2) |
U: 1
|
| GRIN1 | glutamate receptor, ionotropic, NMDA1 (zeta 1) |
U: 1
|
| GRIN2A | glutamate receptor, ionotropic, NMDA2A (epsilon 1) |
U: 1
|
| GRN | granulin |
U: 3
D: 1
|
| GSDMA | gasdermin A |
D: 1
|
| GSK3B | glycogen synthase kinase 3 beta |
U: 1
D: 6
|
| GSN | gelsolin |
U: 5
|
| GSTP1 | glutathione S-transferase, pi 1 |
U: 1
|
| GULP1 | GULP, engulfment adaptor PTB domain containing 1 |
D: 2
|
| GZMB | granzyme B |
U: 1
|
| GABARAP | gamma-aminobutyric acid receptor associated protein |
U: 1
|
| GBA | glucosidase, beta, acid |
U: 3
D: 1
|
| GBE1 | glucan (1,4-alpha-), branching enzyme 1 |
U: 4
|
| GFER | growth factor, augmenter of liver regeneration |
D: 2
|
| GLP1R | glucagon-like peptide 1 receptor |
D: 1
|
| HAX1 | HCLS1 associated X-1 |
D: 1
|
| HCAR2 | hydroxycarboxylic acid receptor 2 |
U: 2
|
| HCLS1 | hematopoietic cell specific Lyn substrate 1 |
U: 1
D: 1
|
| HDAC1 | histone deacetylase 1 |
U: 3
D: 7
|
| HDAC2 | histone deacetylase 2 |
U: 1
D: 4
|
| HDAC3 | histone deacetylase 3 |
D: 2
|
| HDAC4 | histone deacetylase 4 |
U: 1
D: 6
|
| HERPUD1 | homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1 |
U: 1
D: 1
|
| HEY2 | hairy/enhancer-of-split related with YRPW motif 2 |
D: 2
|
| HGF | hepatocyte growth factor |
U: 4
D: 1
|
| HHIP | Hedgehog-interacting protein |
D: 1
|
| HIF1A | hypoxia inducible factor 1, alpha subunit |
U: 4
D: 8
|
| HIF3A | hypoxia inducible factor 3, alpha subunit |
U: 1
D: 1
|
| HIGD2A | HIG1 domain family, member 2A |
U: 1
|
| HINT2 | histidine triad nucleotide binding protein 2 |
D: 2
|
| HIP1 | huntingtin interacting protein 1 |
U: 1
D: 1
|
| HIPK1 | homeodomain interacting protein kinase 1 |
U: 1
|
| HIPK2 | homeodomain interacting protein kinase 2 |
U: 2
|
| HIPK3 | homeodomain interacting protein kinase 3 |
U: 2
|
| HLA-G | major histocompatibility complex, class I, G |
U: 1
|
| HMGA2 | high mobility group AT-hook 2 |
U: 3
D: 2
|
| HMGB1 | high mobility group box 1 |
U: 5
D: 7
|
| HMGCR | 3-hydroxy-3-methylglutaryl-Coenzyme A reductase |
U: 2
D: 2
|
| HMGN5 | high mobility group nucleosome binding domain 5 |
D: 1
|
| HMOX1 | heme oxygenase 1 |
U: 5
D: 6
|
| HNRNPK | heterogeneous nuclear ribonucleoprotein K |
D: 1
|
| HOXA5 | homeobox A5 |
D: 1
|
| HPGD | hydroxyprostaglandin dehydrogenase 15 (NAD) |
U: 2
|
| HRAS | Harvey rat sarcoma virus oncogene |
U: 32
|
| HS1BP3 | HCLS1 binding protein 3 |
U: 1
|
| HSF1 | heat shock factor 1 |
U: 1
D: 3
|
| HSP90AB1 | heat shock protein 90 alpha (cytosolic), class B member 1 |
U: 1
D: 2
|
| HSP90B1 | heat shock protein 90, beta (Grp94), member 1 |
U: 2
D: 1
|
| HSPA1A | heat shock protein family A (Hsp70) member 1A |
U: 3
D: 4
|
| HSPA1B | heat shock protein 1B |
U: 3
D: 2
|
| HSPA5 | heat shock protein 5 |
U: 2
D: 6
|
| HSPA9 | heat shock protein family A (Hsp70) member 9 |
U: 3
D: 2
|
| HSPB1 | heat shock protein family B (small) member 1 |
U: 4
D: 2
|
| HSPB6 | heat shock protein, alpha-crystallin-related, B6 |
U: 1
|
| HSPD1 | heat shock protein 1 (chaperonin) |
U: 1
D: 3
|
| HSPE1 | heat shock protein family E (Hsp10) member 1 |
U: 1
D: 1
|
| HTATIP2 | HIV-1 Tat interactive protein 2 |
U: 1
|
| HYPK | huntingtin interacting protein K |
U: 1
|
| HELLS | helicase, lymphoid specific |
D: 4
|
| HINT1 | histidine triad nucleotide binding protein 1 |
U: 1
|
| HK1 | hexokinase 1 |
U: 1
|
| HOXA13 | homeobox A13 |
U: 2
|
| HSPA4 | heat shock protein 4 |
U: 1
D: 1
|
| HSPA8 | heat shock protein 8 |
U: 2
|
| HSPH1 | heat shock 105kDa/110kDa protein 1 |
U: 2
|
| HYOU1 | hypoxia up-regulated 1 |
U: 1
D: 2
|
| ICAM1 | intercellular adhesion molecule 1 |
U: 16
|
| ID1 | inhibitor of DNA binding 1, HLH protein |
D: 16
|
| ID3 | inhibitor of DNA binding 3 |
U: 1
D: 4
|
| IDO1 | indoleamine 2,3-dioxygenase 1 |
U: 1
D: 3
|
| IER3 | immediate early response 3 |
U: 3
D: 2
|
| IFI27 | interferon alpha inducible protein 27 |
U: 4
D: 3
|
| IFI27L1 | interferon alpha inducible protein 27 like 1 |
D: 1
|
| IFI27L2 | interferon alpha inducible protein 27 like 2 |
U: 2
|
| IFI6 | interferon alpha inducible protein 6 |
U: 4
|
| IFIT2 | interferon-induced protein with tetratricopeptide repeats 2 |
U: 3
|
| IFIT3 | interferon induced protein with tetratricopeptide repeats 3 |
U: 3
D: 1
|
| IFNG | interferon gamma |
U: 13
|
| IFT57 | intraflagellar transport 57 |
D: 2
|
| IGF1 | insulin-like growth factor 1 |
U: 12
D: 7
|
| IGF1R | insulin-like growth factor I receptor |
U: 9
D: 4
|
| IGF2R | insulin-like growth factor 2 receptor |
U: 2
D: 1
|
| IGFBP3 | insulin-like growth factor binding protein 3 |
U: 18
D: 3
|
| IHH | Indian hedgehog |
U: 1
|
| IKBKB | inhibitor of nuclear factor kappa B kinase subunit beta |
U: 2
D: 1
|
| IKBKG | inhibitor of nuclear factor kappa B kinase regulatory subunit gamma |
D: 1
|
| IKZF3 | IKAROS family zinc finger 3 |
U: 1
|
| IL10 | interleukin 10 |
U: 4
D: 3
|
| IL11 | interleukin 11 |
U: 3
D: 4
|
| IL12A | interleukin 12a |
U: 5
|
| IL13 | interleukin 13 |
U: 3
|
| IL1A | interleukin 1 alpha |
U: 31
D: 6
|
| IL1B | interleukin 1 beta |
U: 47
D: 9
|
| IL2 | interleukin 2 |
U: 3
D: 1
|
| IL24 | interleukin 24 |
U: 2
|
| IL2RB | interleukin 2 receptor, beta chain |
U: 1
|
| IL31RA | interleukin 31 receptor A |
U: 1
D: 1
|
| IL4 | interleukin 4 |
U: 4
|
| IL6 | interleukin 6 |
U: 97
D: 19
|
| IL6ST | interleukin 6 signal transducer |
U: 2
D: 1
|
| IL7 | interleukin 7 |
U: 5
|
| IL7R | interleukin 7 receptor |
U: 1
D: 1
|
| ILK | integrin linked kinase |
U: 2
D: 1
|
| ING3 | inhibitor of growth family, member 3 |
D: 3
|
| ING4 | inhibitor of growth family, member 4 |
U: 1
|
| ING5 | inhibitor of growth family, member 5 |
U: 2
D: 1
|
| INPP5D | inositol polyphosphate-5-phosphatase D |
U: 2
|
| IP6K2 | inositol hexaphosphate kinase 2 |
U: 1
|
| IRAK1 | interleukin 1 receptor associated kinase 1 |
U: 2
D: 3
|
| IRF1 | interferon regulatory factor 1 |
U: 5
|
| IRF3 | interferon regulatory factor 3 |
U: 3
|
| IRF5 | interferon regulatory factor 5 |
U: 4
D: 1
|
| IRF7 | interferon regulatory factor 7 |
U: 5
D: 1
|
| IRS2 | insulin receptor substrate 2 |
U: 1
|
| ITGA1 | integrin alpha 1 |
D: 2
|
| ITGA4 | integrin alpha 4 |
U: 1
D: 2
|
| ITGB1 | integrin beta 1 (fibronectin receptor beta) |
U: 3
D: 1
|
| ITGB3BP | integrin beta 3 binding protein (beta3-endonexin) |
D: 2
|
| ITPKB | inositol 1,4,5-trisphosphate 3-kinase B |
U: 2
|
| ITSN1 | intersectin 1 (SH3 domain protein 1A) |
D: 1
|
| IL18 | interleukin 18 |
U: 8
D: 1
|
| IL1RN | interleukin 1 receptor antagonist |
U: 4
D: 1
|
| IL3 | interleukin 3 |
U: 1
|
| ING2 | inhibitor of growth family, member 2 |
U: 2
D: 2
|
| INTS1 | integrator complex subunit 1 |
U: 1
|
| IRAK2 | interleukin-1 receptor-associated kinase 2 |
U: 2
D: 2
|
| ITGAM | integrin alpha M |
U: 1
|
| ITPR1 | inositol 1,4,5-trisphosphate receptor 1 |
U: 4
D: 1
|
| JADE1 | jade family PHD finger 1 |
D: 2
|
| JAG2 | jagged 2 |
U: 4
|
| JAK2 | Janus kinase 2 |
U: 3
|
| JAK3 | Janus kinase 3 |
U: 2
|
| JMY | junction-mediating and regulatory protein |
U: 2
|
| JUN | jun proto-oncogene |
U: 3
D: 4
|
| KALRN | kalirin RhoGEF kinase |
U: 1
D: 1
|
| KANK2 | KN motif and ankyrin repeat domains 2 |
U: 1
D: 1
|
| KCNB1 | potassium voltage gated channel, Shab-related subfamily, member 1 |
U: 2
|
| KCNIP3 | Kv channel interacting protein 3, calsenilin |
U: 2
|
| KCNMA1 | potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
U: 1
D: 1
|
| KDELR1 | KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 1 |
U: 2
|
| KDM2B | lysine (K)-specific demethylase 2B |
D: 4
|
| KDR | kinase insert domain protein receptor |
U: 2
D: 2
|
| KHDC1L | KH domain containing 1 like |
U: 1
|
| KIF14 | kinesin family member 14 |
D: 5
|
| KIF1B | kinesin family member 1B |
U: 1
D: 1
|
| KIFAP3 | kinesin-associated protein 3 |
U: 1
|
| KITLG | KIT ligand |
D: 3
|
| KLF4 | Kruppel-like factor 4 (gut) |
U: 3
D: 5
|
| KLHL20 | kelch-like 20 |
U: 1
|
| KLLN | killin, p53 regulated DNA replication inhibitor |
U: 1
|
| KMT2A | lysine methyltransferase 2A |
U: 1
D: 1
|
| KNG1 | kininogen 1 |
U: 2
|
| KRAS | Kirsten rat sarcoma viral oncogene homolog |
U: 18
D: 3
|
| KREMEN1 | kringle containing transmembrane protein 1 |
U: 2
D: 1
|
| KRIT1 | KRIT1, ankyrin repeat containing |
D: 1
|
| KRT18 | keratin 18 |
U: 1
D: 1
|
| KRT8 | keratin 8 |
D: 1
|
| KLRK1 | killer cell lectin-like receptor subfamily K, member 1 |
U: 1
D: 1
|
| KPNA1 | karyopherin (importin) alpha 1 |
U: 3
|
| LAMP3 | lysosomal-associated membrane protein 3 |
D: 1
|
| LAMTOR5 | late endosomal/lysosomal adaptor, MAPK and MTOR activator 5 |
U: 1
|
| LANCL1 | LanC (bacterial lantibiotic synthetase component C)-like 1 |
U: 1
|
| LATS1 | large tumor suppressor |
D: 2
|
| LATS2 | large tumor suppressor 2 |
U: 2
D: 2
|
| LCK | lymphocyte protein tyrosine kinase |
U: 1
|
| LDHA | lactate dehydrogenase A |
U: 4
D: 2
|
| LEF1 | lymphoid enhancer binding factor 1 |
U: 1
|
| LEP | leptin |
U: 3
D: 1
|
| LGALS1 | lectin, galactose binding, soluble 1 |
U: 2
D: 1
|
| LGALS13 | galectin 13 |
D: 1
|
| LGALS3 | lectin, galactose binding, soluble 3 |
U: 1
D: 2
|
| LGALS9 | galectin 9 |
U: 3
D: 1
|
| LGMN | legumain |
U: 2
D: 1
|
| LHX4 | LIM homeobox protein 4 |
U: 1
D: 1
|
| LIG4 | ligase IV, DNA, ATP-dependent |
U: 2
D: 1
|
| LIMS2 | LIM and senescent cell antigen like domains 2 |
U: 2
|
| LMBR1L | limb region 1 like |
U: 1
|
| LOX | lysyl oxidase |
U: 2
D: 1
|
| LPAR1 | lysophosphatidic acid receptor 1 |
D: 5
|
| LRP1 | low density lipoprotein receptor-related protein 1 |
U: 3
|
| LRP2 | low density lipoprotein receptor-related protein 2 |
U: 1
|
| LRP5 | low density lipoprotein receptor-related protein 5 |
U: 2
|
| LRP6 | low density lipoprotein receptor-related protein 6 |
D: 1
|
| LRP8 | low density lipoprotein receptor-related protein 8, apolipoprotein e receptor |
D: 2
|
| LTA | lymphotoxin A |
U: 1
|
| LTBR | lymphotoxin B receptor |
U: 1
|
| LTF | lactotransferrin |
D: 1
|
| LYN | LYN proto-oncogene, Src family tyrosine kinase |
D: 1
|
| LCN2 | lipocalin 2 |
U: 2
D: 1
|
| LIFR | LIF receptor alpha |
D: 2
|
| LIMS1 | LIM and senescent cell antigen-like domains 1 |
U: 2
|
| LSP1 | lymphocyte specific 1 |
U: 1
D: 3
|
| MAD2L1 | MAD2 mitotic arrest deficient-like 1 |
D: 7
|
| MAEL | maelstrom spermatogenic transposon silencer |
D: 1
|
| MAGED1 | melanoma antigen, family D, 1 |
U: 1
D: 1
|
| MAGI3 | membrane associated guanylate kinase, WW and PDZ domain containing 3 |
D: 3
|
| MAL | mal, T cell differentiation protein |
U: 1
|
| MALT1 | MALT1 paracaspase |
D: 2
|
| MAP1S | microtubule-associated protein 1S |
D: 1
|
| MAP2K4 | mitogen-activated protein kinase kinase 4 |
U: 2
|
| MAP2K6 | mitogen-activated protein kinase kinase 6 |
U: 1
D: 4
|
| MAP2K7 | mitogen-activated protein kinase kinase 7 |
D: 3
|
| MAP3K10 | mitogen-activated protein kinase kinase kinase 10 |
U: 1
|
| MAP3K11 | mitogen-activated protein kinase kinase kinase 11 |
U: 1
|
| MAP3K12 | mitogen-activated protein kinase kinase kinase 12 |
U: 1
|
| MAP3K20 | mitogen-activated protein kinase kinase kinase 20 |
D: 3
|
| MAP3K5 | mitogen-activated protein kinase kinase kinase 5 |
U: 1
D: 1
|
| MAP3K9 | mitogen-activated protein kinase kinase kinase 9 |
U: 4
D: 1
|
| MAP4K4 | mitogen-activated protein kinase kinase kinase kinase 4 |
U: 2
|
| MAPK1 | mitogen-activated protein kinase 1 |
U: 17
D: 6
|
| MAPK14 | mitogen-activated protein kinase 14 |
U: 44
D: 6
|
| MAPK3 | mitogen-activated protein kinase 3 |
U: 10
D: 3
|
| MAPK7 | mitogen-activated protein kinase 7 |
D: 1
|
| MAPK8 | mitogen-activated protein kinase 8 |
U: 5
D: 3
|
| MAPT | microtubule-associated protein tau |
U: 1
D: 1
|
| MCF2 | MCF.2 cell line derived transforming sequence |
U: 1
|
| MCF2L | MCF.2 cell line derived transforming sequence like |
D: 1
|
| MCL1 | myeloid cell leukemia sequence 1 |
U: 3
D: 2
|
| MCM2 | minichromosome maintenance complex component 2 |
D: 6
|
| MDK | midkine |
U: 1
D: 1
|
| MDM2 | transformed mouse 3T3 cell double minute 2 |
U: 6
D: 18
|
| MDM4 | transformed mouse 3T3 cell double minute 4 |
U: 1
D: 2
|
| MECOM | MDS1 and EVI1 complex locus |
U: 1
D: 1
|
| MECP2 | methyl CpG binding protein 2 |
U: 2
D: 3
|
| MEF2A | myocyte enhancer factor 2A |
U: 2
D: 1
|
| MEF2C | myocyte enhancer factor 2C |
D: 1
|
| MEF2D | myocyte enhancer factor 2D |
U: 2
|
| MEGF10 | multiple EGF-like-domains 10 |
U: 1
D: 1
|
| MELK | maternal embryonic leucine zipper kinase |
D: 4
|
| MERTK | MER proto-oncogene tyrosine kinase |
U: 2
|
| MFF | mitochondrial fission factor |
D: 2
|
| MFN2 | mitofusin 2 |
U: 3
|
| MFSD10 | major facilitator superfamily domain containing 10 |
U: 1
|
| MICAL1 | microtubule associated monooxygenase, calponin and LIM domain containing 1 |
D: 1
|
| MIEN1 | migration and invasion enhancer 1 |
U: 1
|
| MIF | macrophage migration inhibitory factor (glycosylation-inhibiting factor) |
U: 2
D: 5
|
| MIR106B | microRNA 106b |
U: 2
D: 1
|
| MIR125A | microRNA 125a |
U: 1
|
| MIR125B1 | microRNA 125b-1 |
U: 1
D: 1
|
| MIR126 | microRNA 126 |
U: 1
D: 2
|
| MIR137 | microRNA 137 |
U: 1
|
| MIR138-1 | microRNA 138-1 |
U: 1
|
| MIR140 | microRNA 140 |
U: 1
|
| MIR145 | microRNA 145 |
U: 1
|
| MIR146A | microRNA 146a |
U: 2
D: 5
|
| MIR15B | microRNA 15b | |
| MIR16-1 | microRNA 16-1 |
U: 1
|
| MIR17 | microRNA 17 |
D: 1
|
| MIR181B1 | microRNA 181b-1 |
U: 1
|
| MIR182 | microRNA 182 |
D: 1
|
| MIR199A1 | microRNA 199a-1 |
U: 1
|
| MIR19B1 | microRNA 19b-1 |
U: 1
|
| MIR20A | microRNA 20a | |
| MIR21 | microRNA 21 |
U: 2
D: 1
|
| MIR221 | microRNA 221 |
D: 1
|
| MIR222 | microRNA 222 |
U: 1
|
| MIR24-1 | microRNA 24-1 |
U: 1
|
| MIR24-2 | microRNA 24-2 | |
| MIR27B | microRNA 27b |
U: 4
|
| MIR29A | microRNA 29a |
U: 3
|
| MIR29B1 | microRNA 29b-1 |
U: 2
|
| MIR29C | microRNA 29c |
U: 2
D: 1
|
| MIR30E | microRNA 30e |
D: 1
|
| MIR320A | microRNA 320a |
U: 1
|
| MIR34A | microRNA 34a |
U: 7
D: 2
|
| MIR590 | microRNA 590 |
D: 1
|
| MIR98 | microRNA 98 |
D: 1
|
| MITF | melanogenesis associated transcription factor |
U: 3
D: 3
|
| MLLT11 | myeloid/lymphoid or mixed-lineage leukemia; translocated to, 11 |
U: 2
D: 2
|
| MMP9 | matrix metallopeptidase 9 |
U: 14
D: 3
|
| MOAP1 | modulator of apoptosis 1 |
U: 1
|
| MPO | myeloperoxidase |
U: 1
|
| MRPL41 | mitochondrial ribosomal protein L41 |
U: 1
|
| MRPS30 | mitochondrial ribosomal protein S30 |
D: 1
|
| MSH2 | mutS homolog 2 |
D: 3
|
| MSX1 | msh homeobox 1 |
D: 1
|
| MSX2 | msh homeobox 2 |
U: 1
D: 3
|
| MT3 | metallothionein 3 |
U: 2
D: 1
|
| MTCH1 | mitochondrial carrier 1 |
U: 1
|
| MTDH | metadherin |
U: 1
D: 1
|
| MTFP1 | mitochondrial fission process 1 |
D: 4
|
| MTOR | mechanistic target of rapamycin kinase |
U: 36
D: 10
|
| MUL1 | mitochondrial ubiquitin ligase activator of NFKB 1 |
U: 1
|
| MX1 | MX dynamin like GTPase 1 |
U: 4
|
| MYB | MYB proto-oncogene, transcription factor |
U: 1
D: 1
|
| MYBL2 | myeloblastosis oncogene-like 2 |
D: 8
|
| MYC | myelocytomatosis oncogene |
U: 7
D: 24
|
| MYD88 | myeloid differentiation primary response gene 88 |
U: 1
|
| MYDGF | myeloid derived growth factor |
U: 1
D: 1
|
| MYOCD | myocardin |
U: 1
|
| MAP3K7 | mitogen-activated protein kinase kinase kinase 7 |
U: 2
|
| MAPK8IP1 | mitogen-activated protein kinase 8 interacting protein 1 |
U: 1
D: 1
|
| MAPK9 | mitogen-activated protein kinase 9 |
U: 1
D: 3
|
| MEN1 | multiple endocrine neoplasia 1 |
U: 1
|
| MIR25 | microRNA 25 |
D: 1
|
| MIR668 | microRNA 668 |
U: 1
|
| MKNK2 | MAP kinase-interacting serine/threonine kinase 2 |
U: 1
|
| MMP2 | matrix metallopeptidase 2 |
U: 11
D: 1
|
| MRE11A | MRE11A homolog A, double strand break repair nuclease |
D: 1
|
| MRTFA | myocardin related transcription factor A | |
| MST1 | macrophage stimulating 1 (hepatocyte growth factor-like) |
U: 1
D: 1
|
| MUSK | muscle, skeletal, receptor tyrosine kinase |
D: 1
|
| NAA15 | N(alpha)-acetyltransferase 15, NatA auxiliary subunit |
D: 2
|
| NAA16 | N(alpha)-acetyltransferase 16, NatA auxiliary subunit |
D: 2
|
| NAE1 | NEDD8 activating enzyme E1 subunit 1 |
U: 1
D: 2
|
| NAIF1 | nuclear apoptosis inducing factor 1 |
D: 1
|
| NCKAP1L | NCK associated protein 1 like |
U: 1
|
| NCSTN | nicastrin |
U: 1
|
| NDNF | neuron-derived neurotrophic factor |
U: 1
D: 1
|
| NDRG1 | N-myc downstream regulated 1 |
U: 4
D: 3
|
| NDUFA13 | NADH:ubiquinone oxidoreductase subunit A13 |
U: 1
|
| NEFL | neurofilament, light polypeptide |
U: 1
|
| NEK6 | NIMA (never in mitosis gene a)-related expressed kinase 6 |
U: 2
D: 4
|
| NES | nestin |
U: 1
D: 3
|
| NET1 | neuroepithelial cell transforming gene 1 |
D: 1
|
| NEURL1 | neuralized E3 ubiquitin protein ligase 1 |
U: 1
|
| NEUROD1 | neurogenic differentiation 1 |
D: 1
|
| NF1 | neurofibromin 1 |
U: 2
D: 2
|
| NF2 | neurofibromin 2 |
U: 1
|
| NFATC4 | nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 4 |
U: 2
D: 1
|
| NFE2L2 | nuclear factor, erythroid derived 2, like 2 |
U: 4
D: 16
|
| NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 |
U: 19
D: 7
|
| NFKBIA | NFKB inhibitor alpha |
U: 2
D: 5
|
| NGEF | neuronal guanine nucleotide exchange factor |
U: 1
D: 2
|
| NGF | nerve growth factor |
U: 3
|
| NGFR | nerve growth factor receptor (TNFR superfamily, member 16) |
U: 2
|
| NIBAN2 | niban apoptosis regulator 2 | |
| NISCH | nischarin |
U: 2
|
| NKX2-5 | NK2 homeobox 5 |
U: 1
|
| NKX3-1 | NK3 homeobox 1 |
U: 2
|
| NKX3-2 | NK3 homeobox 2 |
U: 1
|
| NLRC4 | NLR family, CARD domain containing 4 |
U: 2
|
| NLRP1 | NLR family pyrin domain containing 1 |
U: 1
D: 1
|
| NLRP2 | NLR family, pyrin domain containing 2 |
U: 1
|
| NLRP3 | NLR family, pyrin domain containing 3 |
U: 6
|
| NME1 | NME/NM23 nucleoside diphosphate kinase 1 |
U: 1
D: 1
|
| NME2 | NME/NM23 nucleoside diphosphate kinase 2 |
U: 1
D: 1
|
| NME3 | NME/NM23 nucleoside diphosphate kinase 3 |
U: 2
|
| NME6 | NME/NM23 nucleoside diphosphate kinase 6 |
D: 1
|
| NNT | nicotinamide nucleotide transhydrogenase |
D: 2
|
| NOC2L | NOC2 like nucleolar associated transcriptional repressor |
D: 3
|
| NOD1 | nucleotide-binding oligomerization domain containing 1 |
D: 2
|
| NOD2 | nucleotide-binding oligomerization domain containing 2 |
U: 1
|
| NOL3 | nucleolar protein 3 (apoptosis repressor with CARD domain) |
U: 3
|
| NOP53 | NOP53 ribosome biogenesis factor | |
| NOTCH1 | notch 1 |
U: 8
D: 2
|
| NOX4 | NADPH oxidase 4 |
U: 18
D: 2
|
| NOX5 | NADPH oxidase 5 |
U: 1
|
| NPM1 | nucleophosmin 1 |
U: 3
D: 2
|
| NQO1 | NAD(P)H dehydrogenase, quinone 1 |
U: 1
D: 7
|
| NQO2 | N-ribosyldihydronicotinamide quinone reductase 2 |
D: 1
|
| NR2E1 | nuclear receptor subfamily 2, group E, member 1 |
D: 3
|
| NR3C1 | nuclear receptor subfamily 3, group C, member 1 |
U: 2
D: 1
|
| NR4A2 | nuclear receptor subfamily 4, group A, member 2 |
D: 1
|
| NR4A3 | nuclear receptor subfamily 4, group A, member 3 |
U: 1
|
| NRBP2 | nuclear receptor binding protein 2 |
U: 3
|
| NRP1 | neuropilin 1 |
U: 2
|
| NSG1 | neuron specific gene family member 1 |
U: 3
D: 1
|
| NSMAF | neutral sphingomyelinase (N-SMase) activation associated factor |
U: 1
D: 1
|
| NSMF | NMDA receptor synaptonuclear signaling and neuronal migration factor |
D: 1
|
| NTF3 | neurotrophin 3 |
U: 1
D: 1
|
| NTF4 | neurotrophin 4 |
U: 1
|
| NTN1 | netrin 1 |
U: 5
D: 1
|
| NTRK2 | neurotrophic tyrosine kinase, receptor, type 2 |
U: 2
|
| NTRK3 | neurotrophic tyrosine kinase, receptor, type 3 |
U: 2
|
| NTSR1 | neurotensin receptor 1 |
U: 1
D: 2
|
| NUAK2 | NUAK family, SNF1-like kinase, 2 |
U: 1
|
| NUDT2 | nudix (nucleoside diphosphate linked moiety X)-type motif 2 |
U: 1
|
| NUPR1 | nuclear protein transcription regulator 1 |
U: 4
D: 2
|
| NACA | nascent polypeptide-associated complex alpha polypeptide |
U: 1
|
| NCF2 | neutrophil cytosolic factor 2 |
U: 4
|
| NCL | nucleolin |
D: 1
|
| NCOA3 | nuclear receptor coactivator 3 |
U: 1
D: 2
|
| NDUFAF4 | NADH:ubiquinone oxidoreductase complex assembly factor 4 |
U: 1
|
| NELL1 | NEL-like 1 |
U: 1
D: 2
|
| NOS3 | nitric oxide synthase 3, endothelial cell |
U: 4
D: 12
|
| NPTX1 | neuronal pentraxin 1 |
U: 1
D: 1
|
| NR4A1 | nuclear receptor subfamily 4, group A, member 1 |
U: 2
|
| OBSCN | obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF |
U: 1
D: 2
|
| OGG1 | 8-oxoguanine DNA-glycosylase 1 |
U: 1
D: 7
|
| OGT | O-linked N-acetylglucosamine (GlcNAc) transferase (UDP-N-acetylglucosamine:polypeptide-N-acetylglucosaminyl transferase) |
U: 1
D: 2
|
| OLFM1 | olfactomedin 1 |
U: 2
D: 1
|
| OMA1 | OMA1 zinc metallopeptidase |
D: 1
|
| OPA1 | OPA1, mitochondrial dynamin like GTPase |
U: 2
D: 2
|
| OSGIN1 | oxidative stress induced growth inhibitor 1 |
U: 2
D: 1
|
| OXR1 | oxidation resistance 1 |
U: 1
|
| OPTN | optineurin |
U: 3
D: 1
|
| P2RX1 | purinergic receptor P2X, ligand-gated ion channel, 1 |
U: 1
|
| P2RX7 | purinergic receptor P2X, ligand-gated ion channel, 7 |
D: 1
|
| PA2G4 | proliferation-associated 2G4 |
U: 1
D: 2
|
| PAEP | progestagen associated endometrial protein |
U: 2
|
| PAFAH2 | platelet-activating factor acetylhydrolase 2 |
U: 2
D: 1
|
| PAK1 | p21 (RAC1) activated kinase 1 |
D: 1
|
| PAK2 | p21 (RAC1) activated kinase 2 |
U: 2
|
| PAK3 | p21 (RAC1) activated kinase 3 |
D: 1
|
| PAK4 | p21 (RAC1) activated kinase 4 |
U: 1
D: 1
|
| PAK6 | p21 (RAC1) activated kinase 6 |
U: 2
|
| PARK7 | Parkinson disease (autosomal recessive, early onset) 7 |
U: 1
D: 2
|
| PARP1 | poly (ADP-ribose) polymerase family, member 1 |
U: 5
D: 8
|
| PAWR | PRKC, apoptosis, WT1, regulator |
U: 1
D: 2
|
| PAX3 | paired box 3 |
D: 1
|
| PAX8 | paired box 8 |
U: 1
D: 2
|
| PCID2 | PCI domain containing 2 |
U: 1
D: 1
|
| PCSK9 | proprotein convertase subtilisin/kexin type 9 |
U: 1
D: 1
|
| PDCD1 | programmed cell death 1 |
U: 1
D: 1
|
| PDCD10 | programmed cell death 10 |
U: 2
|
| PDCD4 | programmed cell death 4 |
U: 2
D: 1
|
| PDCD5 | programmed cell death 5 |
U: 1
D: 1
|
| PDCD6 | programmed cell death 6 |
U: 1
D: 1
|
| PDCD6IP | programmed cell death 6 interacting protein |
U: 1
|
| PDCL3 | phosducin-like 3 |
D: 1
|
| PDE1A | phosphodiesterase 1A, calmodulin-dependent |
D: 1
|
| PDE1B | phosphodiesterase 1B |
U: 1
|
| PDE3A | phosphodiesterase 3A, cGMP inhibited |
U: 1
D: 1
|
| PDGFRB | platelet derived growth factor receptor, beta polypeptide |
D: 3
|
| PDPK1 | 3-phosphoinositide dependent protein kinase 1 |
U: 2
|
| PDPN | podoplanin |
U: 1
|
| PDX1 | pancreatic and duodenal homeobox 1 |
D: 1
|
| PEA15 | proliferation and apoptosis adaptor protein 15 |
U: 2
D: 1
|
| PEG10 | paternally expressed 10 |
D: 1
|
| PERP | PERP, TP53 apoptosis effector |
U: 3
|
| PHB | prohibitin |
U: 2
D: 2
|
| PHB2 | prohibitin 2 |
D: 1
|
| PHIP | pleckstrin homology domain interacting protein |
D: 1
|
| PHLDA1 | pleckstrin homology like domain, family A, member 1 |
U: 1
D: 2
|
| PHLDA2 | pleckstrin homology like domain family A member 2 |
U: 2
D: 1
|
| PHLDA3 | pleckstrin homology like domain, family A, member 3 |
U: 1
|
| PHLPP1 | PH domain and leucine rich repeat protein phosphatase 1 |
D: 1
|
| PIAS1 | protein inhibitor of activated STAT 1 |
U: 1
D: 1
|
| PIAS4 | protein inhibitor of activated STAT 4 |
U: 1
|
| PIDD1 | p53 induced death domain protein 1 |
U: 3
|
| PIGT | phosphatidylinositol glycan anchor biosynthesis, class T |
U: 1
|
| PIK3CA | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha |
U: 5
D: 5
|
| PIK3CB | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta |
U: 2
|
| PIK3CD | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta |
U: 2
D: 1
|
| PIK3CG | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma |
U: 2
D: 3
|
| PIK3R1 | phosphoinositide-3-kinase regulatory subunit 1 |
U: 1
|
| PIM1 | proviral integration site 1 |
U: 7
D: 2
|
| PIM2 | proviral integration site 2 |
U: 1
|
| PIM3 | proviral integration site 3 |
U: 2
|
| PIN1 | protein (peptidyl-prolyl cis/trans isomerase) NIMA-interacting 1 |
U: 1
D: 4
|
| PINK1 | PTEN induced putative kinase 1 |
U: 3
D: 5
|
| PITX3 | paired-like homeodomain transcription factor 3 |
D: 1
|
| PKN1 | protein kinase N1 |
D: 1
|
| PKN2 | protein kinase N2 |
D: 1
|
| PLA2G1B | phospholipase A2, group IB, pancreas |
U: 1
|
| PLA2R1 | phospholipase A2 receptor 1 |
U: 5
D: 2
|
| PLAGL1 | PLAG1 like zinc finger 1 |
U: 2
D: 2
|
| PLAUR | plasminogen activator, urokinase receptor |
U: 8
D: 2
|
| PLCG1 | phospholipase C, gamma 1 |
U: 2
|
| PLEKHF1 | pleckstrin homology domain containing, family F (with FYVE domain) member 1 |
D: 2
|
| PLEKHG2 | pleckstrin homology and RhoGEF domain containing G2 |
D: 1
|
| PLEKHG5 | pleckstrin homology and RhoGEF domain containing G5 |
U: 1
|
| PLEKHN1 | pleckstrin homology domain containing, family N member 1 |
U: 1
D: 2
|
| PLK1 | polo like kinase 1 |
D: 13
|
| PLK2 | polo like kinase 2 |
U: 2
D: 1
|
| PLK3 | polo like kinase 3 |
U: 3
D: 1
|
| PLSCR1 | phospholipid scramblase 1 |
U: 2
|
| PLSCR3 | phospholipid scramblase 3 |
U: 1
D: 1
|
| PMAIP1 | phorbol-12-myristate-13-acetate-induced protein 1 |
U: 5
D: 1
|
| PML | promyelocytic leukemia |
U: 15
D: 2
|
| PNMA1 | PNMA family member 1 |
D: 1
|
| PNMA2 | PNMA family member 2 |
U: 1
D: 1
|
| POLB | polymerase (DNA directed), beta |
D: 1
|
| POLR2G | RNA polymerase II subunit G |
D: 1
|
| POU3F3 | POU domain, class 3, transcription factor 3 |
D: 1
|
| POU3F4 | POU domain, class 3, transcription factor 4 |
U: 1
D: 1
|
| POU4F1 | POU domain, class 4, transcription factor 1 |
D: 1
|
| PPARD | peroxisome proliferator activator receptor delta |
U: 3
D: 4
|
| PPARG | peroxisome proliferator activated receptor gamma |
U: 7
D: 8
|
| PPARGC1A | peroxisome proliferative activated receptor, gamma, coactivator 1 alpha |
U: 3
D: 12
|
| PPID | peptidylprolyl isomerase D (cyclophilin D) |
U: 1
D: 1
|
| PPIF | peptidylprolyl isomerase F (cyclophilin F) |
U: 3
D: 1
|
| PPP1R10 | protein phosphatase 1, regulatory subunit 10 |
U: 1
D: 1
|
| PPP1R13B | protein phosphatase 1, regulatory subunit 13B |
D: 1
|
| PPP1R13L | protein phosphatase 1, regulatory subunit 13 like |
U: 2
D: 2
|
| PPP1R15A | protein phosphatase 1, regulatory subunit 15A |
U: 2
D: 2
|
| PPP2CA | protein phosphatase 2 (formerly 2A), catalytic subunit, alpha isoform |
D: 2
|
| PPP2R1A | protein phosphatase 2 scaffold subunit Aalpha |
U: 1
|
| PPP2R1B | protein phosphatase 2, regulatory subunit A, beta |
U: 1
|
| PPP2R2B | protein phosphatase 2, regulatory subunit B, beta |
U: 1
|
| PPT1 | palmitoyl-protein thioesterase 1 |
D: 1
|
| PRAMEF2 | PRAME family member 2 |
U: 1
|
| PRDM11 | PR domain containing 11 |
U: 2
|
| PRDX2 | peroxiredoxin 2 |
U: 1
D: 3
|
| PRDX3 | peroxiredoxin 3 |
D: 1
|
| PRELID1 | PRELI domain containing 1 |
D: 2
|
| PREX1 | phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1 |
U: 2
D: 1
|
| PRF1 | perforin 1 (pore forming protein) |
D: 1
|
| PRKAA1 | protein kinase, AMP-activated, alpha 1 catalytic subunit |
U: 9
D: 11
|
| PRKAA2 | protein kinase, AMP-activated, alpha 2 catalytic subunit |
U: 2
D: 3
|
| PRKCA | protein kinase C, alpha |
U: 3
D: 2
|
| PRKCD | protein kinase C, delta |
U: 7
|
| PRKCH | protein kinase C, eta |
U: 3
D: 1
|
| PRKCI | protein kinase C, iota |
U: 1
D: 2
|
| PRKCQ | protein kinase C, theta |
U: 1
|
| PRKCZ | protein kinase C, zeta |
D: 1
|
| PRKD1 | protein kinase D1 |
U: 2
D: 1
|
| PRKDC | protein kinase, DNA activated, catalytic polypeptide |
U: 1
D: 4
|
| PRKN | parkin RBR E3 ubiquitin protein ligase |
U: 5
D: 1
|
| PRLR | prolactin receptor |
U: 1
|
| PRNP | prion protein |
U: 3
D: 1
|
| PROC | protein C |
U: 1
|
| PRR7 | proline rich 7 (synaptic) |
U: 1
D: 1
|
| PRUNE2 | prune homolog 2 |
U: 2
D: 1
|
| PSEN1 | presenilin 1 |
U: 3
|
| PSEN2 | presenilin 2 |
U: 1
|
| PSENEN | presenilin enhancer, gamma-secretase subunit |
U: 1
D: 1
|
| PSMG2 | proteasome (prosome, macropain) assembly chaperone 2 |
D: 1
|
| PTEN | phosphatase and tensin homolog |
U: 6
D: 20
|
| PTGFR | prostaglandin F receptor |
D: 1
|
| PTGS2 | prostaglandin-endoperoxide synthase 2 |
U: 12
D: 4
|
| PTK2 | PTK2 protein tyrosine kinase 2 |
U: 1
D: 4
|
| PTK2B | PTK2 protein tyrosine kinase 2 beta |
U: 1
|
| PTMA | prothymosin alpha |
D: 2
|
| PTN | pleiotrophin |
D: 4
|
| PTPA | protein phosphatase 2 protein activator |
U: 1
|
| PTPN6 | protein tyrosine phosphatase non-receptor type 6 |
D: 1
|
| PTPRH | protein tyrosine phosphatase receptor type H |
U: 2
|
| PTPRZ1 | protein tyrosine phosphatase, receptor type Z, polypeptide 1 |
U: 3
D: 2
|
| PTRH2 | peptidyl-tRNA hydrolase 2 |
U: 1
D: 1
|
| PUF60 | poly-U binding splicing factor 60 |
D: 1
|
| PYCARD | PYD and CARD domain containing |
U: 1
|
| PAX4 | paired box 4 |
U: 1
|
| PCMT1 | protein-L-isoaspartate (D-aspartate) O-methyltransferase 1 |
U: 2
|
| PCNT | pericentrin (kendrin) |
D: 1
|
| PCP4 | Purkinje cell protein 4 |
D: 1
|
| PDE5A | phosphodiesterase 5A, cGMP-specific |
U: 1
D: 1
|
| PDXK | pyridoxal (pyridoxine, vitamin B6) kinase |
U: 3
|
| PGR | progesterone receptor |
U: 3
D: 2
|
| PLA2G4A | phospholipase A2, group IVA (cytosolic, calcium-dependent) |
U: 1
D: 1
|
| PMP22 | peripheral myelin protein 22 |
U: 1
D: 1
|
| PNP | purine-nucleoside phosphorylase |
U: 1
|
| PSMD9 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 9 |
U: 1
D: 1
|
| PTPRF | protein tyrosine phosphatase, receptor type, F |
U: 1
|
| QARS | glutaminyl-tRNA synthetase |
D: 1
|
| RABEP1 | rabaptin, RAB GTPase binding effector protein 1 |
U: 1
|
| RABGGTA | Rab geranylgeranyltransferase subunit alpha |
U: 2
|
| RABGGTB | Rab geranylgeranyltransferase subunit beta |
U: 1
|
| RACK1 | receptor for activated C kinase 1 |
D: 1
|
| RAD21 | RAD21 cohesin complex component |
D: 2
|
| RAF1 | v-raf-leukemia viral oncogene 1 |
U: 3
D: 1
|
| RALB | v-ral simian leukemia viral oncogene B |
U: 1
D: 1
|
| RAMP2 | receptor (calcitonin) activity modifying protein 2 |
D: 1
|
| RAPGEF2 | Rap guanine nucleotide exchange factor (GEF) 2 |
D: 1
|
| RAPSN | receptor-associated protein of the synapse |
U: 1
|
| RARB | retinoic acid receptor, beta |
U: 2
D: 1
|
| RASA1 | RAS p21 protein activator 1 |
U: 1
|
| RASGRF2 | Ras protein specific guanine nucleotide releasing factor 2 |
U: 1
|
| RASSF2 | Ras association (RalGDS/AF-6) domain family member 2 |
U: 1
D: 1
|
| RASSF3 | Ras association (RalGDS/AF-6) domain family member 3 |
U: 1
|
| RASSF5 | Ras association (RalGDS/AF-6) domain family member 5 |
U: 3
|
| RASSF7 | Ras association (RalGDS/AF-6) domain family (N-terminal) member 7 |
U: 1
|
| RB1 | RB transcriptional corepressor 1 |
U: 37
D: 7
|
| RBM10 | RNA binding motif protein 10 |
D: 2
|
| RBM25 | RNA binding motif protein 25 |
D: 1
|
| RBM5 | RNA binding motif protein 5 |
D: 2
|
| RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
U: 12
D: 5
|
| REST | RE1-silencing transcription factor |
U: 2
|
| RETREG1 | reticulophagy regulator 1 |
U: 2
|
| RFK | riboflavin kinase |
U: 1
|
| RGCC | regulator of cell cycle |
U: 1
D: 2
|
| RGL2 | ral guanine nucleotide dissociation stimulator-like 2 |
D: 1
|
| RGN | regucalcin |
U: 2
D: 6
|
| RHOA | ras homolog family member A |
U: 3
|
| RHOB | ras homolog family member B |
U: 3
D: 1
|
| RIPK1 | receptor (TNFRSF)-interacting serine-threonine kinase 1 |
U: 1
|
| RIPK2 | receptor (TNFRSF)-interacting serine-threonine kinase 2 |
U: 1
D: 1
|
| RMDN3 | regulator of microtubule dynamics 3 |
U: 1
|
| RNF122 | ring finger protein 122 |
U: 1
|
| RNF130 | ring finger protein 130 |
D: 1
|
| RNF144B | ring finger protein 144B |
U: 4
|
| RNF152 | ring finger protein 152 |
U: 3
|
| RNF157 | ring finger protein 157 |
U: 1
|
| RNPS1 | RNA binding protein with serine rich domain 1 |
U: 2
D: 1
|
| ROBO1 | roundabout guidance receptor 1 |
D: 2
|
| ROBO2 | roundabout guidance receptor 2 |
U: 2
D: 2
|
| ROCK1 | Rho-associated coiled-coil containing protein kinase 1 |
D: 1
|
| RPS27A | ribosomal protein S27a |
U: 1
|
| RPS27L | ribosomal protein S27-like |
U: 2
|
| RPS3 | ribosomal protein S3 |
D: 1
|
| RPS3A | ribosomal protein S3A |
D: 1
|
| RPS6 | ribosomal protein S6 |
U: 2
D: 1
|
| RPS6KA1 | ribosomal protein S6 kinase polypeptide 1 |
U: 2
|
| RPS6KA2 | ribosomal protein S6 kinase, polypeptide 2 |
U: 1
D: 2
|
| RPS6KA3 | ribosomal protein S6 kinase polypeptide 3 |
U: 1
|
| RPS6KB1 | ribosomal protein S6 kinase, polypeptide 1 |
U: 11
D: 4
|
| RRAGC | Ras related GTP binding C |
U: 1
|
| RRP1B | ribosomal RNA processing 1 homolog B (S. cerevisiae) |
D: 1
|
| RSL1D1 | ribosomal L1 domain containing 1 |
D: 6
|
| RTN3 | reticulon 3 |
D: 1
|
| RAPGEF3 | Rap guanine nucleotide exchange factor (GEF) 3 |
U: 1
D: 1
|
| RB1CC1 | RB1-inducible coiled-coil 1 |
U: 2
|
| RBCK1 | RanBP-type and C3HC4-type zinc finger containing 1 |
U: 2
D: 2
|
| RBPJ | recombination signal binding protein for immunoglobulin kappa J region |
D: 1
|
| RNF41 | ring finger protein 41 |
U: 1
D: 1
|
| RNF7 | ring finger protein 7 |
U: 2
D: 1
|
| RPS29 | ribosomal protein S29 |
U: 1
|
| RUVBL1 | RuvB-like protein 1 |
U: 1
D: 3
|
| RXRA | retinoid X receptor alpha |
U: 1
D: 2
|
| S100A14 | S100 calcium binding protein A14 |
U: 1
|
| S100A8 | S100 calcium binding protein A8 (calgranulin A) |
U: 2
|
| S100A9 | S100 calcium binding protein A9 (calgranulin B) |
U: 2
D: 1
|
| S100B | S100 protein, beta polypeptide, neural |
D: 1
|
| SAP30BP | SAP30 binding protein |
D: 1
|
| SARM1 | sterile alpha and HEAT/Armadillo motif containing 1 |
D: 1
|
| SAV1 | salvador family WW domain containing 1 |
D: 2
|
| SCG2 | secretogranin II |
U: 1
|
| SCIN | scinderin |
U: 2
|
| SCN2A | sodium channel, voltage-gated, type II, alpha |
U: 2
D: 2
|
| SCRIB | scribbled planar cell polarity |
U: 1
|
| SDF2L1 | stromal cell-derived factor 2-like 1 |
D: 1
|
| SELENOS | selenoprotein S |
D: 1
|
| SEMA3A | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A |
D: 1
|
| SEMA5A | sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A |
U: 1
D: 1
|
| SEMA6A | sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A |
U: 1
D: 2
|
| SENP1 | SUMO1/sentrin specific peptidase 1 |
U: 1
D: 2
|
| SERBP1 | SERPINE1 mRNA binding protein 1 |
U: 1
D: 1
|
| SERPINB13 | serine (or cysteine) peptidase inhibitor, clade B (ovalbumin), member 13 |
U: 1
|
| SERPINB2 | serine (or cysteine) peptidase inhibitor, clade B, member 2 |
U: 9
D: 2
|
| SERPINB9 | serine (or cysteine) peptidase inhibitor, clade B, member 9 |
D: 1
|
| SERPINE1 | serine (or cysteine) peptidase inhibitor, clade E, member 1 |
U: 38
D: 4
|
| SET | SET nuclear oncogene |
U: 1
D: 1
|
| SETX | senataxin |
D: 1
|
| SFN | stratifin |
U: 1
|
| SFRP1 | secreted frizzled-related protein 1 |
U: 1
|
| SFRP2 | secreted frizzled-related protein 2 |
U: 2
|
| SFRP4 | secreted frizzled-related protein 4 |
U: 2
D: 1
|
| SGK1 | serum/glucocorticoid regulated kinase 1 |
U: 3
D: 3
|
| SGMS1 | sphingomyelin synthase 1 |
U: 1
|
| SH3GLB1 | SH3-domain GRB2-like B1 (endophilin) |
U: 1
|
| SH3KBP1 | SH3-domain kinase binding protein 1 |
U: 2
D: 1
|
| SH3RF1 | SH3 domain containing ring finger 1 |
D: 1
|
| SH3RF2 | SH3 domain containing ring finger 2 |
U: 1
|
| SHB | src homology 2 domain-containing transforming protein B |
U: 1
D: 3
|
| SHC1 | src homology 2 domain-containing transforming protein C1 |
U: 7
D: 1
|
| SHF | Src homology 2 domain containing F |
U: 1
D: 1
|
| SHH | sonic hedgehog |
U: 2
D: 1
|
| SIAH2 | siah E3 ubiquitin protein ligase 2 |
D: 1
|
| SIGMAR1 | sigma non-opioid intracellular receptor 1 |
U: 1
D: 2
|
| SIN3A | transcriptional regulator, SIN3A (yeast) |
U: 1
D: 1
|
| SIRT1 | sirtuin 1 |
U: 12
D: 110
|
| SIRT4 | sirtuin 4 |
U: 2
D: 2
|
| SIRT5 | sirtuin 5 |
U: 1
D: 2
|
| SIX1 | sine oculis-related homeobox 1 |
D: 4
|
| SIX4 | sine oculis-related homeobox 4 |
D: 1
|
| SKP2 | S-phase kinase-associated protein 2 |
U: 1
D: 12
|
| SLC25A27 | solute carrier family 25, member 27 |
U: 1
|
| SLC30A10 | solute carrier family 30, member 10 |
D: 1
|
| SLC39A10 | solute carrier family 39 (zinc transporter), member 10 |
U: 1
|
| SLC40A1 | solute carrier family 40 (iron-regulated transporter), member 1 |
U: 1
D: 1
|
| SLC7A11 | solute carrier family 7 (cationic amino acid transporter, y+ system), member 11 |
U: 2
D: 2
|
| SLC9A1 | solute carrier family 9 (sodium/hydrogen exchanger), member 1 |
U: 3
|
| SLIT2 | slit guidance ligand 2 |
D: 1
|
| SLIT3 | slit guidance ligand 3 |
U: 2
D: 1
|
| SLK | STE20-like kinase |
U: 1
|
| SLTM | SAFB-like, transcription modulator |
U: 1
|
| SMAD3 | SMAD family member 3 |
U: 8
D: 1
|
| SMAD6 | SMAD family member 6 |
D: 1
|
| SMO | smoothened, frizzled class receptor |
U: 1
D: 3
|
| SMPD1 | sphingomyelin phosphodiesterase 1, acid lysosomal |
U: 2
|
| SNCA | synuclein, alpha |
U: 3
|
| SNCB | synuclein, beta |
U: 2
|
| SOCS2 | suppressor of cytokine signaling 2 |
U: 2
D: 1
|
| SOCS3 | suppressor of cytokine signaling 3 |
U: 1
D: 2
|
| SOD1 | superoxide dismutase 1, soluble |
U: 5
D: 4
|
| SOD2 | superoxide dismutase 2, mitochondrial |
U: 12
D: 14
|
| SORT1 | sortilin 1 |
U: 1
|
| SOX2 | SRY (sex determining region Y)-box 2 |
U: 3
D: 10
|
| SOX4 | SRY (sex determining region Y)-box 4 |
U: 1
D: 1
|
| SOX8 | SRY (sex determining region Y)-box 8 |
U: 1
D: 1
|
| SOX9 | SRY (sex determining region Y)-box 9 |
U: 2
D: 6
|
| SPHK1 | sphingosine kinase 1 |
U: 3
D: 2
|
| SPHK2 | sphingosine kinase 2 |
D: 1
|
| SPI1 | spleen focus forming virus (SFFV) proviral integration oncogene |
U: 1
|
| SPIN2B | spindlin family member 2B |
U: 1
|
| SPRY2 | sprouty RTK signaling antagonist 2 |
D: 3
|
| SPTLC1 | serine palmitoyltransferase, long chain base subunit 1 |
U: 1
|
| SQSTM1 | sequestosome 1 |
U: 15
D: 4
|
| SRA1 | steroid receptor RNA activator 1 |
U: 1
|
| SRC | Rous sarcoma oncogene |
U: 2
D: 6
|
| SRPK2 | serine/arginine-rich protein specific kinase 2 |
U: 1
|
| SRSF6 | serine and arginine-rich splicing factor 6 |
D: 2
|
| ST20 | suppressor of tumorigenicity 20 |
U: 1
|
| STAT1 | signal transducer and activator of transcription 1 |
U: 12
D: 1
|
| STAT5B | signal transducer and activator of transcription 5B |
U: 4
|
| STEAP3 | STEAP family member 3 |
U: 3
|
| STIL | Scl/Tal1 interrupting locus |
D: 5
|
| STK17A | serine/threonine kinase 17a |
D: 1
|
| STK17B | serine/threonine kinase 17b (apoptosis-inducing) |
D: 1
|
| STK4 | serine/threonine kinase 4 |
U: 1
|
| STK40 | serine/threonine kinase 40 |
U: 1
D: 1
|
| STPG1 | sperm tail PG rich repeat containing 1 |
D: 1
|
| STXBP1 | syntaxin binding protein 1 |
U: 1
|
| SULF1 | sulfatase 1 |
U: 2
|
| SYCP2 | synaptonemal complex protein 2 |
U: 2
D: 1
|
| SYK | spleen tyrosine kinase |
U: 3
D: 1
|
| SYNGAP1 | synaptic Ras GTPase activating protein 1 homolog (rat) |
D: 1
|
| SCML2 | Scm polycomb group protein like 2 |
D: 3
|
| SCP2 | sterol carrier protein 2, liver |
U: 1
|
| SCT | secretin |
U: 2
|
| SELL | selectin, lymphocyte |
U: 1
|
| SGPL1 | sphingosine phosphate lyase 1 |
D: 1
|
| SHISA5 | shisa family member 5 |
U: 1
|
| SIRT2 | sirtuin 2 |
U: 2
D: 4
|
| SIVA1 | SIVA1, apoptosis-inducing factor |
D: 2
|
| SLC11A2 | solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 |
U: 1
|
| SLC25A4 | solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 4 |
U: 3
|
| SMAD4 | SMAD family member 4 |
U: 1
D: 2
|
| SMARCA4 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 |
U: 4
D: 4
|
| SMPD2 | sphingomyelin phosphodiesterase 2, neutral |
U: 1
D: 1
|
| SNAI2 | snail family zinc finger 2 |
U: 1
D: 3
|
| SP110 | Sp110 nuclear body protein |
U: 3
|
| SPOP | speckle-type BTB/POZ protein |
U: 2
D: 1
|
| SPP1 | secreted phosphoprotein 1 |
U: 4
D: 2
|
| SRGN | serglycin |
U: 1
|
| STAT5A | signal transducer and activator of transcription 5A |
U: 6
D: 2
|
| STK11 | serine/threonine kinase 11 |
U: 5
D: 1
|
| STK24 | serine/threonine kinase 24 |
U: 1
D: 2
|
| SYNE1 | spectrin repeat containing, nuclear envelope 1 |
D: 2
|
| TAF10 | TATA-box binding protein associated factor 10 |
U: 1
|
| TAF9 | TATA-box binding protein associated factor 9 |
U: 1
D: 1
|
| TAF9B | TATA-box binding protein associated factor 9B |
D: 1
|
| TAOK2 | TAO kinase 2 |
U: 2
|
| TARDBP | TAR DNA binding protein |
D: 1
|
| TAX1BP1 | Tax1 (human T cell leukemia virus type I) binding protein 1 |
U: 1
D: 2
|
| TBX3 | T-box 3 |
U: 1
D: 3
|
| TCF7 | transcription factor 7, T cell specific |
U: 1
D: 1
|
| TCF7L2 | transcription factor 7 like 2, T cell specific, HMG box |
U: 1
|
| TCHP | trichoplein, keratin filament binding |
D: 1
|
| TCIM | transcriptional and immune response regulator | |
| TCIRG1 | T cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 protein A3 |
U: 1
|
| TCP1 | t-complex protein 1 |
U: 1
D: 1
|
| TCTN3 | tectonic family member 3 |
D: 1
|
| TEK | TEK receptor tyrosine kinase |
D: 2
|
| TERT | telomerase reverse transcriptase |
U: 6
D: 60
|
| TFAP2A | transcription factor AP-2, alpha |
U: 3
D: 1
|
| TFAP4 | transcription factor AP4 |
D: 3
|
| TFPT | TCF3 (E2A) fusion partner |
D: 1
|
| TFRC | transferrin receptor |
U: 1
D: 1
|
| TGFB2 | transforming growth factor, beta 2 |
U: 5
D: 1
|
| TGFB3 | transforming growth factor, beta 3 |
U: 1
D: 1
|
| TGFBR1 | transforming growth factor, beta receptor I |
U: 5
|
| TGFBR2 | transforming growth factor, beta receptor II |
U: 4
D: 1
|
| TGM2 | transglutaminase 2, C polypeptide |
U: 6
|
| THBS1 | thrombospondin 1 |
U: 7
D: 2
|
| THOC1 | THO complex 1 |
U: 1
D: 2
|
| THOC6 | THO complex 6 |
U: 1
D: 4
|
| THRB | thyroid hormone receptor beta |
U: 3
D: 1
|
| TIA1 | cytotoxic granule-associated RNA binding protein 1 |
D: 3
|
| TIAF1 | TGFB1-induced anti-apoptotic factor 1 |
D: 1
|
| TIAM1 | T cell lymphoma invasion and metastasis 1 |
U: 3
|
| TIAM2 | TIAM Rac1 associated GEF 2 |
D: 1
|
| TIGAR | Trp53 induced glycolysis regulatory phosphatase |
U: 2
|
| TIMP1 | tissue inhibitor of metalloproteinase 1 |
U: 9
D: 2
|
| TLR2 | toll like receptor 2 |
U: 3
|
| TLR3 | toll like receptor 3 |
U: 4
D: 1
|
| TMEM102 | transmembrane protein 102 |
U: 1
|
| TMEM14A | transmembrane protein 14A |
D: 1
|
| TMEM214 | transmembrane protein 214 |
U: 2
D: 1
|
| TMEM219 | transmembrane protein 219 |
U: 1
|
| TMF1 | TATA element modulatory factor 1 |
D: 1
|
| TNF | tumor necrosis factor |
U: 48
D: 7
|
| TNFAIP1 | TNF alpha induced protein 1 |
U: 1
|
| TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 |
U: 3
|
| TNFAIP8 | tumor necrosis factor, alpha-induced protein 8 |
U: 1
|
| TNFAIP8L1 | tumor necrosis factor, alpha-induced protein 8-like 1 |
D: 3
|
| TNFAIP8L3 | tumor necrosis factor, alpha-induced protein 8-like 3 |
U: 4
|
| TNFRSF10A | TNF receptor superfamily member 10a |
U: 1
D: 1
|
| TNFRSF10B | tumor necrosis factor receptor superfamily, member 10b |
U: 3
D: 1
|
| TNFRSF10C | TNF receptor superfamily member 10c |
U: 4
D: 1
|
| TNFRSF10D | TNF receptor superfamily member 10d |
U: 6
|
| TNFRSF11B | tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin) |
U: 2
|
| TNFRSF12A | tumor necrosis factor receptor superfamily, member 12a |
U: 3
D: 2
|
| TNFRSF18 | tumor necrosis factor receptor superfamily, member 18 |
U: 1
|
| TNFRSF19 | TNF receptor superfamily member 19 |
D: 2
|
| TNFRSF1A | tumor necrosis factor receptor superfamily, member 1a |
U: 4
D: 1
|
| TNFRSF1B | tumor necrosis factor receptor superfamily, member 1b |
U: 3
D: 2
|
| TNFRSF21 | tumor necrosis factor receptor superfamily, member 21 |
U: 3
D: 2
|
| TNFRSF25 | TNF receptor superfamily member 25 |
U: 1
|
| TNFRSF6B | TNF receptor superfamily member 6b |
D: 1
|
| TNFRSF8 | tumor necrosis factor receptor superfamily, member 8 |
D: 1
|
| TNFRSF9 | tumor necrosis factor receptor superfamily, member 9 |
U: 2
|
| TNFSF10 | tumor necrosis factor (ligand) superfamily, member 10 |
U: 5
D: 1
|
| TNFSF12 | tumor necrosis factor (ligand) superfamily, member 12 |
U: 1
|
| TNFSF15 | tumor necrosis factor (ligand) superfamily, member 15 |
U: 4
D: 1
|
| TNFSF18 | TNF superfamily member 18 |
U: 1
|
| TNFSF9 | TNF superfamily member 9 |
U: 2
|
| TNIP2 | TNFAIP3 interacting protein 2 |
U: 1
|
| TNS4 | tensin 4 |
U: 1
|
| TOMM22 | translocase of outer mitochondrial membrane 22 |
D: 2
|
| TOP2A | topoisomerase (DNA) II alpha |
D: 10
|
| TOPORS | TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase |
U: 1
|
| TOX3 | TOX high mobility group box family member 3 |
D: 1
|
| TP53 | tumor protein p53 |
U: 243
D: 9
|
| TP53BP2 | tumor protein p53 binding protein 2 |
U: 1
D: 1
|
| TP53I3 | tumor protein p53 inducible protein 3 |
U: 3
|
| TP53INP1 | tumor protein p53 inducible nuclear protein 1 |
U: 5
|
| TP63 | tumor protein p63 |
U: 4
D: 5
|
| TP73 | tumor protein p73 |
U: 4
D: 2
|
| TPX2 | TPX2, microtubule-associated |
D: 7
|
| TRADD | TNFRSF1A-associated via death domain |
U: 1
|
| TRAF1 | TNF receptor-associated factor 1 |
U: 4
|
| TRAF3 | TNF receptor-associated factor 3 |
U: 2
|
| TRAF4 | TNF receptor associated factor 4 |
U: 1
|
| TRAF5 | TNF receptor-associated factor 5 |
U: 1
D: 1
|
| TRAF6 | TNF receptor-associated factor 6 |
U: 1
D: 3
|
| TRAF7 | TNF receptor-associated factor 7 |
U: 1
|
| TRAIP | TRAF interacting protein |
D: 4
|
| TREM2 | triggering receptor expressed on myeloid cells 2 |
D: 1
|
| TRIAP1 | TP53 regulated inhibitor of apoptosis 1 |
U: 2
|
| TRIM2 | tripartite motif-containing 2 |
D: 2
|
| TRIM24 | tripartite motif-containing 24 |
D: 2
|
| TRIM35 | tripartite motif-containing 35 |
U: 2
|
| TRIM69 | tripartite motif-containing 69 |
U: 1
|
| TRIO | trio Rho guanine nucleotide exchange factor |
U: 1
D: 1
|
| TRPV1 | transient receptor potential cation channel, subfamily V, member 1 |
U: 2
|
| TSLP | thymic stromal lymphopoietin |
U: 1
D: 1
|
| TSPO | translocator protein |
U: 1
|
| TWIST1 | twist basic helix-loop-helix transcription factor 1 |
D: 13
|
| TWIST2 | twist basic helix-loop-helix transcription factor 2 |
D: 3
|
| TXNDC5 | thioredoxin domain containing 5 |
D: 1
|
| TXNIP | thioredoxin interacting protein |
U: 8
D: 3
|
| TYRO3 | TYRO3 protein tyrosine kinase 3 |
U: 1
D: 2
|
| TAOK1 | TAO kinase 1 |
U: 2
|
| TGFA | transforming growth factor alpha |
U: 1
D: 1
|
| TGFB1 | transforming growth factor, beta 1 |
U: 49
D: 4
|
| TGFBR3 | transforming growth factor, beta receptor III |
U: 2
D: 2
|
| TICAM1 | toll-like receptor adaptor molecule 1 |
U: 1
|
| TLR4 | toll-like receptor 4 |
U: 7
D: 1
|
| TM2D1 | TM2 domain containing 1 |
U: 1
|
| TMTC4 | transmembrane and tetratricopeptide repeat containing 4 |
D: 2
|
| TNFSF4 | tumor necrosis factor (ligand) superfamily, member 4 |
U: 1
D: 1
|
| TOMM40 | translocase of outer mitochondrial membrane 40 |
D: 2
|
| TRIB3 | tribbles pseudokinase 3 |
U: 3
D: 2
|
| TRIP10 | thyroid hormone receptor interactor 10 |
U: 1
|
| TRP53BP2 | transformation related protein 53 binding protein 2 |
U: 1
|
| TRP63 | transformation related protein 63 |
U: 2
D: 1
|
| TRP73 | transformation related protein 73 |
D: 3
|
| TRPM7 | transient receptor potential cation channel, subfamily M, member 7 |
D: 1
|
| TRPV2 | transient receptor potential cation channel, subfamily V, member 2 |
U: 2
|
| TSC22D1 | TSC22 domain family, member 1 |
D: 1
|
| UACA | uveal autoantigen with coiled-coil domains and ankyrin repeats |
U: 1
|
| UBB | ubiquitin B |
U: 1
|
| UBC | ubiquitin C |
D: 1
|
| UBD | ubiquitin D |
U: 3
|
| UBE2B | ubiquitin-conjugating enzyme E2B |
U: 2
|
| UBE2D3 | ubiquitin-conjugating enzyme E2D 3 |
U: 1
|
| UBE2M | ubiquitin-conjugating enzyme E2M |
D: 1
|
| UBE2Z | ubiquitin-conjugating enzyme E2Z |
U: 2
D: 1
|
| UCN | urocortin |
U: 1
|
| UFL1 | UFM1 specific ligase 1 |
D: 1
|
| UFM1 | ubiquitin-fold modifier 1 |
U: 2
|
| UMODL1 | uromodulin-like 1 |
U: 1
|
| UNC13B | unc-13 homolog B |
U: 1
|
| UNC5A | unc-5 netrin receptor A |
U: 2
|
| UNC5B | unc-5 netrin receptor B |
U: 2
|
| UNC5C | unc-5 netrin receptor C |
U: 1
D: 1
|
| UNC5D | unc-5 netrin receptor D |
U: 1
D: 1
|
| UNG | uracil DNA glycosylase |
D: 1
|
| USP36 | ubiquitin specific peptidase 36 |
D: 1
|
| USP47 | ubiquitin specific peptidase 47 |
U: 1
|
| USP53 | ubiquitin specific peptidase 53 |
U: 1
|
| UTP11 | UTP11 small subunit processome component | |
| UBE2V2 | ubiquitin-conjugating enzyme E2 variant 2 |
D: 2
|
| UCP2 | uncoupling protein 2 (mitochondrial, proton carrier) |
U: 2
D: 2
|
| USP7 | ubiquitin specific peptidase 7 |
D: 2
|
| VAV3 | vav guanine nucleotide exchange factor 3 |
U: 3
D: 2
|
| VDR | vitamin D (1,25-dihydroxyvitamin D3) receptor |
U: 1
D: 2
|
| VEGFA | vascular endothelial growth factor A |
U: 10
D: 5
|
| VHL | von Hippel-Lindau tumor suppressor |
D: 2
|
| VIP | vasoactive intestinal polypeptide |
U: 1
|
| VPS35 | VPS35 retromer complex component |
U: 1
|
| VSTM2L | V-set and transmembrane domain containing 2-like |
U: 2
|
| VTCN1 | V-set domain containing T cell activation inhibitor 1 |
U: 1
|
| WDR35 | WD repeat domain 35 |
D: 2
|
| WFS1 | wolframin ER transmembrane glycoprotein |
U: 1
|
| WNK3 | WNK lysine deficient protein kinase 3 |
D: 1
|
| WNT1 | wingless-type MMTV integration site family, member 1 |
U: 1
D: 1
|
| WNT11 | wingless-type MMTV integration site family, member 11 |
U: 1
|
| WNT3A | wingless-type MMTV integration site family, member 3A |
U: 2
|
| WNT5A | wingless-type MMTV integration site family, member 5A |
U: 4
|
| WNT7A | wingless-type MMTV integration site family, member 7A |
U: 1
D: 1
|
| WNT9A | wingless-type MMTV integration site family, member 9A |
U: 2
|
| WRN | Werner syndrome RecQ like helicase |
U: 1
D: 8
|
| WT1 | Wilms tumor 1 homolog |
D: 1
|
| WNT7B | wingless-type MMTV integration site family, member 7B |
U: 3
D: 3
|
| WWOX | WW domain-containing oxidoreductase |
U: 2
D: 1
|
| XAF1 | XIAP associated factor 1 |
U: 3
|
| XBP1 | X-box binding protein 1 |
U: 3
D: 1
|
| XDH | xanthine dehydrogenase |
U: 2
D: 2
|
| XIAP | X-linked inhibitor of apoptosis |
U: 2
D: 1
|
| XKR5 | X-linked Kx blood group related 5 |
D: 1
|
| XKR9 | X-linked Kx blood group related 9 |
U: 1
|
| XRCC2 | X-ray repair complementing defective repair in Chinese hamster cells 2 |
D: 3
|
| XRCC4 | X-ray repair complementing defective repair in Chinese hamster cells 4 |
D: 4
|
| YAP1 | yes-associated protein 1 |
U: 6
D: 13
|
| YME1L1 | YME1-like 1 (S. cerevisiae) |
U: 1
|
| YWHAE | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon |
U: 1
D: 1
|
| YWHAZ | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta |
U: 1
D: 2
|
| YBX1 | Y box protein 1 |
U: 1
D: 5
|
| YBX3 | Y box protein 3 |
U: 1
|
| YPEL3 | yippee like 3 |
U: 6
|
| YWHAH | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide |
U: 1
|
| ZBTB16 | zinc finger and BTB domain containing 16 |
U: 1
|
| ZBTB7A | zinc finger and BTB domain containing 7a |
U: 2
D: 3
|
| ZC3H12A | zinc finger CCCH type containing 12A |
U: 3
|
| ZDHHC16 | zinc finger, DHHC domain containing 16 |
D: 1
|
| ZFAND6 | zinc finger, AN1-type domain 6 |
D: 1
|
| ZFP36 | zinc finger protein 36 |
U: 2
D: 2
|
| ZFP36L1 | zinc finger protein 36, C3H type-like 1 |
U: 2
D: 2
|
| ZMAT3 | zinc finger matrin type 3 |
U: 4
D: 1
|
| ZMPSTE24 | zinc metallopeptidase, STE24 |
D: 2
|
| ZNF16 | zinc finger protein 16 |
D: 1
|
| ZNF268 | zinc finger protein 268 |
D: 1
|
| ZNF385A | zinc finger protein 385A |
U: 1
|
| ZNF443 | zinc finger protein 443 |
U: 1
|
| ZNF622 | zinc finger protein 622 |
U: 1
|
| ZNF830 | zinc finger protein 830 |
D: 1
|
| ZPR1 | ZPR1 zinc finger |
D: 3
|